Obesity

E4_OBESITY

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66 Cause of death: ICD-10 — E66 2 out of 7 registries used, show all original rules.	38671
4. Check minimum number of events None	38671
5. Include endpoints E4_OBESITYCAL E4_OBESITYDRUG E4_OBESITYXTRMALV E4_OBESITYNAS	39836
6. Filter based on genotype QC (FinnGen only)	35801

Control definitions (FinnGen only)

Control exclude: E4_OBESITY_HYPER

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E65-E68
Name in latin: Obesitas

NAME	E4_OBESITY
CONTROL_EXCLUDE	E4_OBESITY_HYPER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_OBESITYCAL\|E4_OBESITYDRUG\|E4_OBESITYXTRMALV\|E4_OBESITYNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E66
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E66
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Obesity based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	207520	122748	83494
Only index persons	188132	112943	75189
Unadjusted period prevalence (%)
Whole population	3.03	3.52	2.33
Only index persons	3.64	4.15	2.87
Median age at first event (years)
Whole population	48.54	46.90	50.95
Only index persons	47.74	45.65	50.87

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	35801	23990	11811
Unadjusted period prevalence (%)	7.49	8.52	5.42
Median age at first event (years)	50.88	48.30	56.13

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
37156: Matched controls
349599

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K07

ICPC

Swollen ankles/oedema

2.8

323.3

1698

5827

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

323.0

2987

13344

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

323.0

9807

63505

K04.0

ICD-10 Finland

Pulpitis

2.0

322.3

3926

19462

M01AB05

ATC

diclofenac; systemic, rectal

1.5

320.6

23788

187415

N06AB06

ATC

sertraline; oral

1.9

318.0

4655

24554

I50

ICD-10 Finland

Heart failure

3.8

317.1

998

2501

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.1

317.0

899

2089

S10

ICPC

Boil/carbuncle

2.4

316.5

2472

10283

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.8

315.8

1721

6024

M79.7

ICD-10 Finland

Fibromyalgia

2.8

315.0

1673

5777

SFA30

NOMESCO Finland

Three-surface restoration

1.5

314.4

15492

111745

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.9

311.9

1575

5292

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

311.2

7684

47168

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

310.9

10493

69559

J46

ICD-10 Finland

Status asthmaticus

3.2

310.1

1274

3801

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

308.8

5180

28504

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

307.7

5359

20579

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

307.7

5303

25978

R03BA05

ATC

fluticasone; inhalant

1.8

307.7

7029

39653

C07AB07

ATC

bisoprolol; oral

2.0

307.7

17199

105333

SGA01

NOMESCO Finland

Emergency treatment

1.8

307.7

6782

38825

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

307.7

4630

24227

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

8693

53287

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.5

307.7

4982

20707

P01AB01

ATC

metronidazole; oral, rectal

1.5

307.7

14757

104340

C09AA02

ATC

enalapril; systemic

2.2

307.7

6439

31052

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.7

307.7

6135

14257

A10BB12

ATC

glimepiride; oral

4.3

307.7

2815

6608

B01AA03

ATC

warfarin; systemic

2.0

307.7

5170

26511

A10BG03

ATC

pioglitazone; oral

5.5

307.7

1299

2299

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

307.7

7702

45693

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

21.8

307.7

1109

493

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.4

307.7

5098

21880

A10BX07

ATC

[U] liraglutide

19.0

307.7

1221

623

B01AB05

ATC

enoxaparin; parenteral

2.2

307.7

13016

67670

C03DA01

ATC

spironolactone; oral

2.8

307.7

5219

18975

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

307.7

11635

61743

M25.5

ICD-10 Finland

Pain in joint

1.6

307.7

12768

86075

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2902.0

307.7

3366

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

6.4

307.7

801

1192

A10AE05

ATC

insulin detemir; parenteral

3.3

307.7

2433

7331

SPAT1263

SPAT

Sampling

1.6

307.7

15384

106044

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

11431

57377

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.4

307.7

7018

22287

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

307.7

7522

39876

S18

ICPC

Laceration/cut

1.6

307.7

16875

117955

103

Kela drug reimbursment

Diabetes, insulin-treated

4.2

307.7

14755

47603

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.1

307.7

5495

6563

358

Kela drug reimbursment

liraglutide

17.8

307.7

441

236

RD210, ,

NOMESCO Finland

7.0

307.7

1241

1715

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

307.7

14234

97743

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.3

307.7

596

898

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.2

307.7

969

2210

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

307.7

3998

17931

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.7

307.7

2151

7757

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

307.7

5241

26043

SPAT1240

SPAT

Therapeutic discussion

1.9

307.7

4461

23054

A10AC01

ATC

insulin (human); parenteral

3.4

307.7

3588

10662

M79.6

ICD-10 Finland

Pain in limb

1.8

307.7

17631

117366

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

307.7

17104

112765

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.4

307.7

7276

23342

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.1

307.7

5902

28369

A08AA62

ATC

bupropion and naltrexone; systemic

13.3

307.7

749

538

N06AB10

ATC

escitalopram; oral

1.8

307.7

8567

50997

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

9704

60770

C09BA02

ATC

enalapril and diuretics; systemic

2.5

307.7

2634

10254

E66.0

ICD-10 Finland

Obesity due to excess calories

480.9

307.7

1707

A10BJ02

ATC

liraglutide; parenteral

13.9

307.7

3304

2440

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.7

307.7

2029

7426

R06.5

ICD-10 Finland

Mouth breathing

2.3

307.7

3762

16481

H02AB06

ATC

prednisolone; systemic

1.8

307.7

18203

120492

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

307.7

3203

12923

N06AB03

ATC

fluoxetine; oral

2.2

307.7

5192

23915

L03

ICPC

Low back symptom/complaint

1.7

307.7

11582

73579

J01AA02

ATC

doxycycline; systemic

1.8

307.7

28311

225551

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.9

307.7

867

1688

N03AX12

ATC

[U] gabapentin; oral

1.9

307.7

5997

31692

N06AX16

ATC

venlafaxine; oral

2.2

307.7

6738

31637

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.5

307.7

10198

46517

L15

ICPC

Knee symptom/complaint

1.9

307.7

10107

58008

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

307.7

855

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

307.7

5808

28950

J01FF01

ATC

clindamycin; systemic

2.0

307.7

11034

61280

XCK10

NOMESCO Finland

Photography of fundus of eye

2.3

307.7

3341

14328

WX722

NOMESCO Finland

PEEP

4.9

307.7

2589

5219

N02AX02

ATC

tramadol; systemic, rectal

2.2

307.7

17788

103094

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

307.7

11311

70632

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

307.7

21108

157739

N06AB04

ATC

citalopram; systemic

2.0

307.7

8257

44302

N06AX12

ATC

bupropion; oral

2.5

307.7

3824

15193

A10BA02

ATC

metformin; oral

5.2

307.7

17355

50764

A08AA02

ATC

fenfluramine; oral

8.2

307.7

534

619

C10AA01

ATC

simvastatin; oral

1.8

307.7

12375

77476

C10AA05

ATC

atorvastatin; oral

1.6

307.7

13440

90994

N06AX11

ATC

mirtazapine; oral

1.6

307.7

12442

84852

J01DA01

ATC

[U] cefalexin

1.7

307.7

22605

168948

A10BB01

ATC

glibenclamide; oral

3.9

307.7

1089

2679

A10BD07

ATC

metformin and sitagliptin; systemic

3.4

307.7

1794

5163

E66.01

ICD-10 Finland

Obesity due to excess calories

83.0

307.7

22186

6131

N05AH04

ATC

quetiapine; oral

2.1

307.7

7716

39286

S97

ICPC

Chronic ulcer skin

3.1

307.7

2614

8343

A10BH01

ATC

sitagliptin; oral

4.2

307.7

5126

12785

A08AB01

ATC

orlistat; oral

24.1

307.7

673

267

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

307.7

2133

8122

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

307.7

4143

20481

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

307.7

8434

49448

A46

ICD-10 Finland

Erysipelas

2.8

307.7

6679

25057

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.2

307.7

4573

14887

XG466

NOMESCO Finland

Sleep oxymetry

6.0

307.7

1889

3116

M04AA01

ATC

allopurinol; systemic

3.1

307.7

5309

17704

EBA00

NOMESCO Finland

Extraction of tooth

1.6

307.7

13992

94760

P06

ICPC

Sleep disturbance

2.0

307.7

5780

28966

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

307.7

8722

53032

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

307.7

2318

8798

SPAT1262

SPAT

Handing over of treatment supplies

3.1

307.7

8364

29591

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

307.7

2822

10993

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

307.7

5703

30450

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

307.7

3621

17020

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

307.7

4533

20125

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.5

307.7

1334

2891

R03BB04

ATC

tiotropium bromide; inhalant

2.3

307.7

3398

14725

OAB50, ,

SPAT

2.5

307.7

3476

13903

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

307.7

3520

15677

R03AC02

ATC

salbutamol; inhalant

2.2

307.7

23172

151748

A08AA10

ATC

sibutramine; oral

22.9

307.7

347

144

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

17466

128486

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.0

307.7

3939

5846

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

307.7

4731

21327

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

307.7

8747

50528

162

Kela drug reimbursment

liraglutide

17.9

307.7

1043

562

I10

ICD-10 Finland

Essential (primary) hypertension

2.8

307.7

24068

138949

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.8

307.7

1902

3875

A10AE04

ATC

insulin glargine; parenteral

3.7

307.7

5154

14663

205

Kela drug reimbursment

Chronic hypertension

2.7

307.7

9810

41347

H03AA01

ATC

levothyroxine sodium; systemic

1.8

307.7

8711

51100

WX723

NOMESCO Finland

CPAP therapy

3.5

307.7

2366

6753

M03BX02

ATC

tizanidine; oral

1.5

307.7

23149

180560

M10.9

ICD-10 Finland

Gout, unspecified

3.1

307.7

2803

8893

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

1358.5

307.7

973

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.2

307.7

1636

3068

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

307.7

4937

20307

N03AX09

ATC

lamotrigine; oral

2.5

307.7

2258

8880

ACC51

NOMESCO Finland

Release of median nerve

2.2

307.7

3073

13530

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

5.8

307.7

2858

4931

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

307.7

1471

4416

SPAT1310

SPAT

Counselling related to known health issue

1.6

307.7

11464

74533

3055, ,

Kela drug reimbursment

14.3

307.7

753

505

E66.8

ICD-10 Finland

Other obesity

134.4

307.7

13501

1478

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

307.7

2343

8680

L17

ICPC

Foot/toe symptom/complaint

1.8

307.7

12112

73621

A10BJ06

ATC

semaglutide; parenteral

8.6

307.7

5043

6287

J01DB01

ATC

cefalexin; oral

2.2

307.7

31921

255633

G47.3

ICD-10 Finland

Sleep apnoea

5.5

307.7

16686

45270

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

307.7

10186

65216

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

9598

59468

E66.1

ICD-10 Finland

Drug-induced obesity

84.4

307.7

408

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.7

307.7

1690

4444

C09AA05

ATC

ramipril; oral

1.7

307.7

7341

43508

160

Kela drug reimbursment

exenatide

18.3

307.7

1987

1077

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

307.7

6381

29126

C03AA03

ATC

hydrochlorothiazide; oral

2.7

307.7

3225

11755

C09CA01

ATC

losartan; oral

1.8

307.7

8580

50673

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.3

307.7

3876

16638

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

307.7

3646

17447

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.2

307.7

8231

40241

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

367.6

307.7

1750

C02AC05

ATC

moxonidine; oral

3.3

307.7

1821

5439

K02.1

ICD-10 Finland

Caries of dentine

1.6

307.7

23188

175636

B03BA03

ATC

hydroxocobalamin; parenteral

3.0

307.7

2020

6649

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

307.7

2847

11860

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.1

307.7

13970

44978

3051, ,

Kela drug reimbursment

13.2

307.7

1182

868

J01MA12

ATC

levofloxacin; systemic

1.8

307.7

6175

34926

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.6

307.7

2086

7692

207

Kela drug reimbursment

Chronic arrhythmias

1.9

307.7

4439

22784

A10BK01

ATC

dapagliflozin; oral

3.6

307.7

4154

11705

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.1

307.7

4928

23384

P03

ICPC

Feeling depressed

2.0

307.7

4693

23597

L28

ICPC

Limited function/disability (L)

2.1

307.7

6726

33793

XX_20

NOMESCO Finland

Bioimpedance measurement

28.8

307.7

252

N03AX16

ATC

[U] pregabalin

2.0

307.7

8895

48096

E66.9

ICD-10 Finland

Obesity, unspecified

73.4

307.7

7489

1198

S76

ICPC

Skin infection other

2.6

307.7

2212

8339

SPAT1254

SPAT

Administration of medicine

1.9

307.7

5060

26597

A02BC02

ATC

pantoprazole; systemic

2.0

307.7

26098

189693

R02

ICPC

Shortness of breath/dyspnoea

2.2

307.7

5654

26290

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.9

307.7

1291

2524

A08

ICPC

Swelling

3.0

307.7

2423

7879

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

307.7

8302

50633

M54.5

ICD-10 Finland

Low back pain

1.8

307.7

15180

95802

N05BA04

ATC

oxazepam; oral

1.7

307.7

9711

60427

J01FA06

ATC

roxithromycin; oral

1.6

307.7

13934

96635

OAB72

NOMESCO Finland

Weight control and weight loss guidance

28.1

307.7

1253

434

R03DC03

ATC

montelukast; oral

1.8

307.7

6453

37008

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

17236

114147

T82

ICPC

Obesity

12.9

307.7

5616

4755

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

307.7

6975

41286

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.2

307.7

4382

19754

C08CA13

ATC

lercanidipine; oral

2.1

307.7

5031

24468

C03CA01

ATC

furosemide; systemic

3.2

307.7

12402

46734

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.7

307.7

6220

23959

T83

ICPC

Overweight

5.3

307.7

1759

3236

R60.0

ICD-10 Finland

Localized oedema

2.4

307.7

5221

22049

N06AX21

ATC

duloxetine; oral

2.3

307.7

5457

24389

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

307.7

27841

217562

A10AB05

ATC

insulin aspart; parenteral

3.2

307.7

3663

11712

E11

ICD-10 Finland

Type 2 diabetes mellitus

3.9

307.7

8650

25452

N02BE01

ATC

paracetamol; systemic, rectal

2.8

307.7

34061

279675

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

5.3

307.7

1058

1929

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.8

307.7

14156

39703

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

307.7

7986

41998

C09DA01

ATC

losartan and diuretics; oral

2.1

307.7

3702

17223

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.4

307.7

1007

2195

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.5

307.7

5437

22149

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.5

307.7

5057

20626

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

307.7

1032

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

307.7

10921

71229

T90

ICPC

Diabetes non-insulin dependent

4.0

307.7

13499

43551

WX290

NOMESCO Finland

Other blockage of nerve

1.7

307.7

19417

138469

N05AX12

ATC

aripiprazole; systemic

3.0

307.7

2108

6870

T07

ICPC

Weight gain

4.4

307.7

980

2146

R4190

NOMESCO Finland

Nutritional therapy

5.8

307.7

3046

5290

A10BJ01

ATC

exenatide; parenteral

12.9

307.7

817

606

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

307.7

7430

41738

J96.1

ICD-10 Finland

Chronic respiratory failure

6.1

307.7

1008

1601

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

11677

76842

A10BJ05

ATC

dulaglutide; parenteral

8.6

307.7

1566

1775

E66.00

ICD-10 Finland

Metabolic syndrome

40.2

307.7

10227

3269

QBJ30

NOMESCO Finland

Correction of abdominal apron

32.0

307.7

1132

343

R5140

NOMESCO Finland

Monitoring the use of the aid

4.7

307.7

7451

17766

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

307.7

3040

13534

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

17479

111872

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

307.7

14406

99488

A28

ICPC

Limited function/disability NOS

1.9

307.7

5133

27435

A10BX04

ATC

[U] exenatide

19.6

307.7

947

467

I50.0

ICD-10 Finland

Congestive heart failure

3.3

307.7

2449

7400

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

307.7

19605

147504

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

307.7

8671

39425

A10BH05

ATC

linagliptin; oral

3.5

307.7

2057

5723

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.4

307.7

5928

6943

E66

ICD-10 Finland

Obesity

12.2

307.7

7320

6910

WX780

NOMESCO Finland

Remote monitoring CPAP

3.6

307.7

2489

6785

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

307.7

2830

12269

J45

ICD-10 Finland

Asthma

2.0

307.7

4330

21240

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

15596

110907

P76

ICPC

Depressive disorder

2.3

307.7

3260

13993

A10BK03

ATC

empagliflozin; oral

3.9

307.7

5706

15611

C08CA01

ATC

amlodipine; oral

2.0

307.7

13518

78354

I50.9

ICD-10 Finland

Heart failure, unspecified

3.1

307.7

4867

16425

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.6

307.7

1589

4300

R03BA02

ATC

budesonide; inhalant

1.8

307.7

6749

38772

OAB72, ,

SPAT

7.0

307.7

1379

1904

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.0

307.7

1289

3083

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

307.7

3514

16297

Z3226

NOMESCO Finland

Physiotherapist

1.8

307.7

6428

35575

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

307.6

4760

25542

M01AE02

ATC

naproxen; oral, rectal

1.5

306.9

20788

159904

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

306.7

8313

52233

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

306.5

6702

39807

W85

ICPC

Gestational diabetes

2.6

306.0

1913

7176

C09DA06

ATC

candesartan and diuretics; oral

2.2

303.7

2721

11989

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

303.0

7167

43461

M01AH05

ATC

etoricoxib; oral

1.5

302.7

22870

179703

C07AB02

ATC

metoprolol; systemic

1.8

302.4

5762

32913

SFA20

NOMESCO Finland

Two-surface restoration

1.5

302.1

22149

172919

SPAT1139

SPAT

Nutrition survey

3.1

301.8

1332

4147

Z71.8

ICD-10 Finland

Other specified counselling

1.5

298.9

13097

91842

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

298.2

1457

4806

W84

ICPC

Pregnancy high risk

2.7

296.1

1726

6251

ZXD05

NOMESCO Finland

Urgent procedure

1.6

295.6

10525

70468

C09CA06

ATC

candesartan; oral

1.6

295.4

8612

55012

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.2

294.9

817

1865

N05CF01

ATC

zopiclone; oral

1.6

294.8

10447

69862

N05AA02

ATC

levomepromazine; systemic

2.8

293.5

1571

5444

K04.08

ICD-10 Finland

Other specified pulpit

2.0

292.7

3423

16693

M10

ICD-10 Finland

Gout

2.8

292.1

1592

5569

R96

ICPC

Asthma

2.0

291.7

3756

18946

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

290.8

4698

25516

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

290.7

3994

20593

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

288.3

5731

33090

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

287.2

5291

29888

R5110, ,

SPAT

2.1

286.6

2956

13757

R06AE07

ATC

cetirizine; oral

1.5

285.7

16250

119935

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

285.6

25056

201776

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

284.0

4151

21832

R03AC03

ATC

terbutaline; inhalant

1.8

283.9

5025

28044

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.5

282.7

1846

7066

A01

ICPC

Pain general/multiple sites

1.9

281.6

3734

19012

M10.0

ICD-10 Finland

Idiopathic gout

3.1

281.0

1240

3858

SFA10

NOMESCO Finland

One-surface restoration

1.5

281.0

20640

160061

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

280.4

11893

82536

L90

ICPC

Osteoarthrosis of knee

2.2

279.8

2429

10552

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.9

278.6

837

2028

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

278.3

8794

57132

J20

ICD-10 Finland

Acute bronchitis

1.9

277.4

4099

21624

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

276.0

2375

10278

R01AD09

ATC

mometasone; nasal

1.5

275.4

16955

126793

SPAT1301

SPAT

No procedures

1.5

274.2

10462

70888

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

274.1

4775

26502

N02BF01

ATC

gabapentin; oral

1.9

273.5

3930

20541

A02BC01

ATC

omeprazole; systemic

1.6

272.6

9090

59748

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

272.1

1741

6598

B81

ICPC

Anaemia vit B12/folate deficiency

2.9

271.7

1315

4312

B01AB04

ATC

dalteparin; parenteral

2.5

271.7

1906

7543

A10BX01

ATC

guar gum; oral

3.2

271.2

1147

3480

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

270.9

9932

66673

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

270.4

4329

23411

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

269.9

4870

27302

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

267.7

11997

84029

B01AF02

ATC

apixaban; oral

1.9

266.8

3904

20514

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

265.8

4586

25360

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

264.8

19948

154637

M48.0

ICD-10 Finland

Spinal stenosis

1.9

264.0

3763

19602

A10AD05

ATC

insulin aspart; parenteral

4.8

263.3

609

1203

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.7

262.7

501

832

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

262.0

6337

38477

A10BG02

ATC

rosiglitazone; oral

5.3

261.1

542

974

SPAT1229

SPAT

Assessment of need for aid

2.2

260.9

2352

10368

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

260.4

3076

15028

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

259.3

9279

61845

R4110

NOMESCO Finland

Physiotherapy

1.5

258.3

9337

62361

SPAT1283

SPAT

Restricted health certificate

1.6

257.7

7192

45240

C01DA14

ATC

isosorbide mononitrate; oral

1.9

257.7

3685

19209

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.2

257.4

551

1018

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

257.3

27100

223728

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

256.7

3933

20958

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

5.8

256.1

480

784

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

255.5

11528

80669

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.7

254.7

608

1233

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

8.1

254.6

353

416

WZC30

NOMESCO Finland

Teaching

1.7

254.5

5688

33802

L16

ICPC

Ankle symptom/complaint

1.8

253.7

4529

25274

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

252.8

4256

23340

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

251.9

3224

16189

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

5.3

251.7

519

927

A10BD03

ATC

metformin and rosiglitazone; systemic

5.0

251.5

564

1085

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.7

251.4

1445

5190

AA40B, ,

NOMESCO Finland

9.3

250.4

310

316

D11

ICPC

Diarrhoea

1.7

249.5

4819

27502

R53

ICD-10 Finland

Malaise and fatigue

1.5

248.7

9084

60720

J01CF05

ATC

flucloxacillin; systemic

2.1

248.4

2729

12979

N02BF02

ATC

pregabalin; oral

2.1

248.3

2650

12467

A10BH02

ATC

vildagliptin; oral

4.1

247.1

701

1628

H3600, E113,

ICD-10 Finland

5.5

246.2

489

844

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

244.1

2627

12395

S80.0

ICD-10 Finland

Contusion of knee

2.0

241.5

3056

15277

R05

ICPC

Cough

1.5

241.0

9105

61231

B01AB10

ATC

tinzaparin; parenteral

1.8

240.2

3855

20815

J01MA02

ATC

ciprofloxacin; systemic

1.5

239.9

12600

90597

WX402

NOMESCO Finland

General anaesthesia

1.6

239.2

8168

53713

C09CA03

ATC

valsartan; oral

2.0

238.7

2959

14684

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.8

237.4

742

1849

F34.1

ICD-10 Finland

Dysthymia

2.5

236.3

1568

6039

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.1

236.2

2290

10380

A06AD11

ATC

lactulose; oral

1.8

235.2

4152

23059

SPAT1260

SPAT

Consultation of another employee

1.6

234.8

5928

36278

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.3

234.8

936

2738

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

45.7

234.7

145

N06AA09

ATC

amitriptyline; systemic

1.9

234.7

3085

15616

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

234.3

2679

12917

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

233.8

9940

68445

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

233.2

8609

57538

H02AB07

ATC

prednisone; oral

1.7

232.6

4417

25047

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

231.7

2933

14654

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

230.4

2568

12265

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.7

229.5

4706

27256

N02AA05

ATC

oxycodone; systemic

1.7

229.3

5283

31568

R03BA01

ATC

beclometasone; inhalant

1.7

229.1

4711

27306

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.0

229.1

667

1579

R51.80

ICD-10 Finland

Headache

1.6

228.6

6006

37098

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

228.4

4302

24331

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.8

225.6

1217

4228

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

225.3

8717

58776

J01FA09

ATC

clarithromycin; systemic

1.5

224.5

10944

77317

J01CA04

ATC

amoxicillin; systemic

1.5

223.6

30104

256524

M02AA07

ATC

piroxicam; topical

1.5

223.6

11043

78201

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

223.0

1182

4068

SPAT1211

SPAT

Application of soft bandage

1.9

222.6

2903

14644

C08CA02

ATC

felodipine; oral

2.0

222.1

2657

13010

D07AC01

ATC

betamethasone; topical

1.4

220.1

12462

90503

N05BA01

ATC

diazepam; systemic, rectal

1.7

220.1

4197

23804

SPAT1312

SPAT

General health counselling

1.5

218.5

10969

77842

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.5

217.8

787

2163

P29

ICPC

Psychological sympt/compl other

1.9

216.5

3174

16631

N62

ICD-10 Finland

Hypertrophy of breast

2.3

216.3

1671

6891

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

215.2

9396

64838

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

13.0

214.2

212

154

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.9

213.8

3205

16910

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.2

213.3

890

2676

A10BX09

ATC

[U] dapagliflozin

5.6

213.1

418

713

A12BA01

ATC

potassium chloride; oral

2.9

212.9

1075

3604

R03DA04

ATC

theophylline; systemic, rectal

2.5

212.5

1433

5558

N06AX26

ATC

vortioxetine; oral

1.9

212.4

3099

16209

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.2

212.3

587

1337

H02AB04

ATC

methylprednisolone; systemic

1.7

211.8

4772

28299

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

210.9

1723

7277

N05AX08

ATC

risperidone; systemic

2.0

209.9

2596

12850

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

208.0

13013

95972

R74

ICPC

Upper respiratory infection acute

1.4

207.5

12960

95542

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

206.0

4164

23973

P99

ICPC

Psychological disorders other

2.5

205.2

1347

5157

WX320

NOMESCO Finland

Spinalanesthesy

1.5

204.9

7952

53481

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

204.6

2625

13154

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

203.0

2826

14549

B01AF01

ATC

rivaroxaban; oral

1.8

201.9

3694

20674

A03

ICPC

Fever

1.5

201.8

6637

43058

H3601, E113,

ICD-10 Finland

4.4

201.7

521

1126

SPAT1255

SPAT

Intravenous administration of medicine

2.0

200.5

2199

10425

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

200.5

4738

28412

E0000UV, ,

ATC

1.4

200.5

14650

110809

C07AG02

ATC

carvedilol; oral

2.3

199.9

1672

7129

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

198.8

8285

56483

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

198.5

3685

20704

S29

ICPC

Skin symptom/complaint other

1.5

198.4

6984

45965

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

4.1

198.3

565

1316

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.5

196.7

1316

5083

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

196.5

3418

18843

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.5

196.2

1252

4728

L60.0

ICD-10 Finland

Ingrowing nail

2.2

196.2

1800

7970

F50.8

ICD-10 Finland

Other eating disorders

6.9

195.6

311

429

N05CD07

ATC

temazepam; oral

1.8

195.0

3171

17134

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

194.9

5379

33490

D01AC02

ATC

miconazole; topical

2.0

194.9

2333

11410

R06.2

ICD-10 Finland

Wheezing

2.2

194.6

1681

7263

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

194.6

3161

17073

CL2S4, ,

SPAT

3.0

194.2

918

2967

UJF32

NOMESCO Finland

Coloscopy

1.5

194.1

8126

55406

K08.3

ICD-10 Finland

Retained dental root

1.9

193.5

2629

13420

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.4

193.2

1456

5935

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

193.1

3199

17379

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

192.7

2533

12788

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

192.5

2268

11028

C01AA05

ATC

digoxin; systemic

2.2

191.9

1746

7703

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.7

191.7

4211

24757

M54

ICD-10 Finland

Dorsalgia

1.6

190.7

4682

28320

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

190.6

3283

18038

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

2.9

190.2

938

3103

L30.4

ICD-10 Finland

Erythema intertrigo

3.6

190.1

638

1669

F32

ICD-10 Finland

Depressive episode

2.0

189.1

2256

11017

SGC10

NOMESCO Finland

Pulp capping

1.8

189.0

3317

18323

RD112, ,

NOMESCO Finland

11.9

189.0

197

156

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

188.7

4413

26360

C09DA03

ATC

valsartan and diuretics; oral

2.3

188.6

1505

6289

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

4.1

187.6

530

1227

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.3

186.6

741

2161

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

185.7

5837

37408

N06AX03

ATC

mianserin; oral

2.2

185.2

1594

6875

A02BC05

ATC

esomeprazole; systemic

1.4

185.0

13479

101479

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

184.1

3047

16538

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

183.6

1793

8132

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

183.4

3462

19518

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

181.5

2386

12040

M01AH01

ATC

celecoxib; oral

1.6

181.3

5575

35534

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

181.2

1168

4431

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

180.9

1005

3542

SPAT1216

SPAT

Assessment of functional ability

1.6

180.6

4240

25333

N05AN01

ATC

lithium; oral

2.7

180.4

987

3451

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

179.7

766

2332

WX002

NOMESCO Finland

Sedation and analgesia

1.5

179.3

5772

37158

A04

ICPC

Weakness/tiredness general

1.6

179.1

5469

34793

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

178.6

7499

51033

R04

ICPC

Breathing problem other

2.3

178.4

1435

6014

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

178.4

8295

57579

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

178.2

4010

23695

XA420

NOMESCO Finland

Extensive sleep examination

4.2

178.1

482

1080

N18.8

ICD-10 Finland

Other chronic renal failure

3.1

177.7

759

2313

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

177.2

1085

4015

J01FA10

ATC

azithromycin; systemic

1.4

176.6

20742

168079

N05AF03

ATC

chlorprothixene; systemic

2.7

176.3

1011

3621

A02BC03

ATC

lansoprazole; oral

1.4

175.6

8759

61576

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.7

175.6

3533

20261

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

175.2

4154

24866

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.7

175.0

3910

23053

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

174.9

2934

15978

I50.1

ICD-10 Finland

Left ventricular failure

2.4

173.7

1277

5146

A10AE06

ATC

insulin degludec; parenteral

2.4

172.6

1306

5330

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

172.4

4242

25625

ZY010

NOMESCO Finland

Hospital outpatient

2.0

172.2

1948

9326

RD140, ,

NOMESCO Finland

66.7

171.6

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

170.5

1114

4252

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

170.2

12907

97427

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

170.2

9102

64742

C10AA07

ATC

rosuvastatin; oral

1.4

169.9

10585

77328

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

169.4

4878

30584

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.8

169.3

867

2927

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

169.2

5142

32640

J02AC01

ATC

fluconazole; systemic

1.4

167.3

14088

108052

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

167.1

10023

72703

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

166.7

2009

9833

Z2446

NOMESCO Finland

Social worker

1.9

166.1

2153

10803

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.3

165.9

650

1880

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.5

165.7

1049

3944

SPAT1377

SPAT

Polysomnography

2.4

165.1

1176

4671

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

164.9

4039

24351

P01

ICPC

Feeling anxious/nervous/tense

1.5

164.7

5171

33045

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

164.2

24737

207160

H01

ICPC

Ear pain/earache

1.6

164.2

4419

27257

OAB42, ,

SPAT

1.6

164.0

4662

29125

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.2

163.9

1419

6130

J01DA09

ATC

[U] cefadroxil

1.4

163.6

8787

62467

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.4

163.4

1140

4486

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

163.0

2970

16552

R4110, ,

SPAT

1.6

162.5

4390

27097

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.9

162.0

793

2612

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.7

161.3

3508

20512

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

161.1

1619

7417

J45.8

ICD-10 Finland

Mixed asthma

2.5

160.6

1075

4149

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

160.4

10489

77091

E65

ICD-10 Finland

Localized adiposity

18.6

160.3

132

WZC00, ,

SPAT

1.5

160.2

5266

33972

R01AD08

ATC

fluticasone; nasal

1.4

160.1

9854

71681

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.9

159.0

2091

10539

N05AH03

ATC

olanzapine; systemic

1.9

158.3

2232

11508

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.3

158.2

1247

5179

R11

ICD-10 Finland

Nausea and vomiting

1.7

158.1

2980

16759

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

157.9

7142

49144

R32

ICD-10 Finland

Unspecified urinary incontinence

2.7

157.5

908

3260

L14

ICPC

Leg/thigh symptom/complaint

1.8

157.2

2731

15005

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

157.1

1284

5415

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

156.9

816

2777

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

156.6

3464

20335

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

156.6

1604

7400

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

156.5

2257

11720

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

155.7

6454

43653

M01AX17

ATC

nimesulide; oral

1.5

154.8

6827

46724

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.1

154.6

431

988

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

153.3

14351

111396

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

153.2

787

2661

K77

ICPC

Heart failure

3.2

152.3

626

1864

A10BD20

ATC

metformin and empagliflozin; oral

3.5

152.2

546

1493

SPAT1094

SPAT

Continuous Positive Airway Pressure

4.0

151.6

447

1068

J96.0

ICD-10 Finland

Acute respiratory failure

4.1

151.5

428

991

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

151.1

1723

8265

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

1.9

150.9

2024

10263

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

150.8

2785

15565

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

150.8

2989

17036

L08

ICPC

Shoulder symptom/complaint

1.4

150.5

7596

53271

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

150.1

1946

9756

CK2S4, ,

SPAT

3.2

150.0

623

1867

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

149.9

2434

13103

N19

ICD-10 Finland

Unspecified kidney failure

2.5

149.6

1009

3908

M01AX05

ATC

glucosamine; oral

1.5

149.2

4900

31560

D07AC13

ATC

mometasone; topical

1.4

149.2

9352

68080

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

148.7

737

2444

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

148.6

9757

71566

M01AB01

ATC

indometacin; systemic, rectal

1.9

148.6

1928

9669

EB1VA, ,

NOMESCO Finland

1.5

148.0

6421

43763

R4190, ,

SPAT

4.7

147.7

349

702

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.5

147.7

987

3806

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

147.0

11624

87786

N06AX05

ATC

trazodone; oral

2.5

146.9

944

3573

K04.09

ICD-10 Finland

Pulpit UNS

2.0

146.5

1780

8729

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

146.5

657

2060

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

146.0

6266

42600

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

145.9

6342

43224

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

145.5

5191

34011

M01AC06

ATC

meloxicam; systemic, rectal

1.4

145.2

11281

84921

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

145.2

1319

5806

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.1

145.1

1470

6750

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.6

145.0

487

1275

ZXE00

NOMESCO Finland

One hour or less

1.3

144.8

12515

95747

L86

ICPC

Back syndrome with radiating pain

1.9

144.7

2108

10973

N05AB03

ATC

perphenazine; systemic, rectal

2.3

144.6

1176

4947

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.2

144.6

605

1821

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

144.4

5932

39981

R03AC13

ATC

formoterol; inhalant

2.1

144.3

1546

7249

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

144.2

1338

5939

A10AB06

ATC

insulin glulisine; parenteral

4.1

144.1

408

946

R03AC12

ATC

salmeterol; inhalant

2.2

144.0

1301

5714

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.6

143.8

889

3303

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

143.3

1914

9689

SPAT1234

SPAT

Support of social functional capacity

2.1

143.1

1429

6527

ZXA00

NOMESCO Finland

Right side

1.4

142.9

7365

51775

C03BA11

ATC

indapamide; oral

2.7

142.4

821

2947

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

142.2

2026

10471

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.2

141.6

1218

5244

AN1

Coronary angiography

1.7

140.8

2585

14413

N03AG01

ATC

valproic acid; systemic, rectal

1.9

140.8

1986

10231

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

140.8

2814

16063

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

140.7

1251

5459

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.3

140.7

540

1542

G44.2

ICD-10 Finland

Tension-type headache

1.5

140.4

4858

31604

SPAT1281

SPAT

Other administrative function

1.8

140.1

2499

13819

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

140.1

12644

97228

U04

ICPC

Incontinence urine

2.0

139.7

1656

8048

L68.0

ICD-10 Finland

Hirsutism

4.5

139.3

352

748

M79.1

ICD-10 Finland

Myalgia

1.5

139.2

5244

34714

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

138.9

1034

4187

R52.9

ICD-10 Finland

Pain, unspecified

1.6

138.9

3547

21550

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

138.5

136

C10AX09

ATC

ezetimibe; oral

1.5

138.4

4985

32696

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

138.1

8757

63717

L13

ICPC

Hip symptom/complaint

1.5

137.9

5953

40468

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

137.7

3645

22330

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

137.4

3319

19888

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

137.3

3059

17960

SPAT1104

SPAT

Monitoring of emergency patient

1.9

137.2

1928

9919

C10AB05

ATC

fenofibrate; oral

3.0

136.6

627

1992

SPAT1058

SPAT

PEF monitoring instruction

1.7

136.2

2458

13635

E000001, ,

ATC

1.4

135.9

6423

44393

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

135.7

1838

9343

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

135.7

1202

5237

EBA30

NOMESCO Finland

Extraction of root of tooth

1.9

135.4

1784

8986

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.1

135.3

1372

6301

J01MA14

ATC

moxifloxacin; systemic

1.7

134.9

2712

15498

R50.9

ICD-10 Finland

Fever, unspecified

1.5

134.7

4889

32098

AA1AD

NOMESCO Finland

CT of head and brain

1.4

134.7

8211

59314

R01AD12

ATC

fluticasone furoate; nasal

1.3

134.7

11335

86132

A08AA01

ATC

phentermine; oral

7.2

134.3

203

265

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.8

134.0

686

2315

SPAT1097

SPAT

Recording of ECG

1.6

133.7

3983

25063

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

133.7

2301

12588

F50.3

ICD-10 Finland

Atypical bulimia nervosa

5.1

133.5

290

543

B02AA02

ATC

tranexamic acid; systemic

1.5

133.3

5079

33671

R42

ICD-10 Finland

Dizziness and giddiness

1.4

133.0

7060

49799

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.4

132.7

960

3837

D07AD01

ATC

clobetasol; topical

1.5

132.3

5391

36210

A99

ICPC

Disease/condition unspecnature/site

1.6

132.1

3365

20416

Z01.2

ICD-10 Finland

Dental examination

1.3

132.0

16797

135199

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.0

131.6

585

1825

R01AD58

ATC

fluticasone, combinations; nasal

1.4

131.5

9153

67508

QDB10, ,

SPAT

2.5

131.3

851

3234

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

131.2

3244

19539

D07XC01

ATC

betamethasone; topical

1.6

130.9

3628

22454

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.6

130.8

807

2995

T92

ICPC

Gout

2.9

130.6

639

2104

SPAT1054

SPAT

Examination of peripheral nervous system

3.1

130.5

553

1677

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

130.5

1835

9439

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

2.4

130.4

919

3630

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

129.9

1649

8201

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.1

129.9

1360

6319

SPAT1153

SPAT

Removal of sutures

1.4

129.2

9237

68374

40199

ICD-8 Finland

Essential benign hypertension

3.5

129.2

460

1252

TFP20

NOMESCO Finland

Cardiodefibrillation

1.9

129.1

1846

9545

IHZ05, ,

SPAT

1.9

129.0

1789

9160

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

128.8

4805

31699

KGH10

NOMESCO Finland

Operation for phimosis

2.6

128.4

776

2851

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

128.4

830

3150

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

128.3

1202

5354

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

128.1

1107

4773

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.8

128.0

653

2199

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.1

128.0

356

815

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.3

127.3

978

4014

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.2

126.7

1149

5052

C08DB01

ATC

diltiazem; oral

2.2

126.7

1154

5083

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

126.2

1206

5412

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.2

126.0

1104

4787

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

125.8

2553

14615

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

22.1

125.3

C09CA07

ATC

telmisartan; oral

1.8

125.1

2176

11934

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

125.1

3373

20729

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.6

124.8

759

2797

C02EA02, ,

ATC

2.4

124.7

922

3721

G04BD12

ATC

mirabegron; oral

1.6

124.6

3288

20102

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

124.6

7173

51223

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

124.5

1421

6812

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

124.5

2123

11578

N05CF02

ATC

zolpidem; oral

1.4

124.4

5606

38336

N05BA12

ATC

alprazolam; oral

1.6

124.2

3034

18208

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.6

124.0

748

2745

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

123.7

1768

9139

N06AB05

ATC

paroxetine; oral

1.8

123.5

2003

10761

OAB74, ,

SPAT

3.2

123.3

499

1472

D10

ICPC

Vomiting

1.7

123.3

2267

12630

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.1

123.1

1156

5152

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.5

122.9

3863

24569

N03AX11

ATC

topiramate; oral

2.3

122.6

952

3925

K85

ICPC

Elevated blood pressure

1.5

122.4

4693

31103

R21

ICPC

Throat symptom/complaint

1.4

122.4

7936

57760

M02AA10

ATC

ketoprofen; topical

1.5

122.0

4743

31521

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

121.9

3005

18071

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

121.6

9459

70802

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

121.4

1253

5789

M09AX01

ATC

hyaluronic acid; parenteral

2.1

121.4

1186

5367

A10BX02

ATC

repaglinide; oral

3.7

121.1

396

1018

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

121.1

1043

4491

G93.2

ICD-10 Finland

Benign intracranial hypertension

7.9

120.9

170

204

A02BA02

ATC

ranitidine; systemic

1.5

120.8

5187

35133

L12

ICPC

Hand/finger symptom/complaint

1.4

120.7

5806

40159

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

120.5

1249

5780

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.6

120.5

742

2751

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.3

120.3

920

3768

ZXA05

NOMESCO Finland

Left side

1.4

120.0

6721

47730

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.9

120.0

601

2004

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

120.0

3322

20531

A08AX01

ATC

rimonabant; oral

21.4

119.8

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.5

119.4

1078

20309

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

119.4

3550

22296

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

119.1

2184

12154

C09DA07

ATC

telmisartan and diuretics; oral

2.1

118.9

1243

5770

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

118.8

1532

7656

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

1.7

118.8

2211

12357

RK320, ,

NOMESCO Finland

4.4

118.5

303

650

Z2221

NOMESCO Finland

Medical doctor

1.4

118.4

8657

64144

S20

ICPC

Corn/callosity

2.7

117.7

650

2282

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

117.5

1761

9236

R99

ICPC

Respiratory disease other

2.7

116.9

671

2403

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

116.3

4260

27956

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

5.6

116.0

225

380

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

116.0

2738

16284

N01

ICPC

Headache

1.5

115.3

4063

26448

R29

ICPC

Respiratory symptom/complaint other

1.7

115.3

2285

12987

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

115.2

4209

27602

SPAT1051

SPAT

Guidance regarding sleep disorders

2.8

114.9

583

1958

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

114.8

3682

23498

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

114.4

9914

75250

JAH01

NOMESCO Finland

Laparoscopy

1.9

114.3

1589

8137

K78

ICPC

Atrial fibrillation/flutter

1.8

114.2

1801

9592

M15

ICD-10 Finland

Polyarthrosis

1.9

114.1

1445

7177

XF402

NOMESCO Finland

ECG with work load test

1.6

113.6

2765

16566

C07BB07

ATC

bisoprolol and thiazides; systemic

2.2

113.3

1047

4636

J01DA06

ATC

[U] cefuroxime

1.5

113.3

4394

29154

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.9

113.0

254

490

XQ800

NOMESCO Finland

Prick test

1.6

112.8

2533

14871

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

112.8

1922

10470

N30.0

ICD-10 Finland

Acute cystitis

1.4

112.6

5649

39311

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

112.5

1513

7664

P74

ICPC

Anxiety disorder/anxiety state

1.8

112.1

1740

9220

WX723, ,

SPAT

3.6

111.6

379

1000

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

111.1

1281

6159

A29

ICPC

General symptom/complaint other

1.5

110.9

4055

26582

Z01.7

ICD-10 Finland

Laboratory examination

1.4

110.3

5511

38312

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

110.1

3902

25414

S21

ICPC

Skin texture symptom/complaint

1.4

110.1

4784

32426

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.4

110.0

815

3292

R4180, ,

SPAT

3.2

109.6

440

1292

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.8

109.1

1915

10520

M01AH02

ATC

rofecoxib; oral

1.5

108.9

3357

21229

R52.2

ICD-10 Finland

Other chronic pain

2.0

108.8

1237

5919

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.7

108.7

347

878

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.4

108.6

761

2998

WZC30, ,

SPAT

1.6

108.6

2677

16081

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

4.5

108.4

267

556

N06AA12

ATC

doxepin; systemic

1.9

108.4

1401

7004

ZXA10

NOMESCO Finland

Bilateral

1.4

107.9

5123

35279

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

107.8

1225

5859

C09AA03

ATC

lisinopril; oral

2.0

107.6

1143

5336

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

4.7

107.5

255

515

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

107.2

1906

10508

WX111

NOMESCO Finland

Local infiltration anesthesia

2.1

107.1

1018

4558

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

107.0

1576

8216

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

106.7

2967

18331

R06AX27

ATC

desloratadine; oral

1.3

106.6

10120

77628

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.7

106.4

576

2002

SPAT1059

SPAT

Spirometry at the office

1.9

106.2

1440

7312

A08AA04

ATC

dexfenfluramine; oral

9.3

106.2

131

133

N02AJ13

ATC

tramadol and paracetamol; systemic

2.4

106.2

781

3144

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.3

106.1

850

3550

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

105.8

1770

9588

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

105.6

1809

9867

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.4

105.5

733

2876

D07AA02

ATC

hydrocortisone; topical

1.4

105.5

4495

30333

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.5

105.4

659

2461

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

104.7

1164

5524

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

104.5

2356

13838

212

Kela drug reimbursment

Gout

2.9

104.4

501

1632

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

104.2

1436

7330

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

104.0

1916

10666

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

104.0

1775

9670

WX892

NOMESCO Finland

Monitored bed care

1.7

103.9

2135

12242

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.5

103.7

654

2453

A97

ICPC

No disease

1.4

103.3

6436

46364

A10BD15

ATC

metformin and dapagliflozin; oral

3.7

103.2

337

866

IGY02, ,

SPAT

2.6

102.9

639

2379

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.1

102.8

982

4404

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.8

102.5

532

1809

OAB93, ,

SPAT

1.6

102.4

2614

15825

N04BC05

ATC

pramipexole; oral

1.7

102.1

2086

11944

E68

ICD-10 Finland

Sequelae of hyperalimentation

33.7

102.0

K04.00

ICD-10 Finland

Hyperemia of pulp

1.8

102.0

1644

8807

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

102.0

2293

13457

D01

ICPC

Abdominal pain/cramps general

1.5

102.0

4232

28405

O61.0

ICD-10 Finland

Failed medical induction of labour

3.2

101.8

419

1249

M76.6

ICD-10 Finland

Achilles tendinitis

1.8

101.7

1627

8696

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.4

101.7

751

3029

A10AB04

ATC

insulin lispro; parenteral

2.1

101.6

1006

4574

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.2

101.6

424

1275

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

101.5

1268

6266

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

101.5

1184

5715

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.4

101.5

375

1046

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.4

101.3

737

2953

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.0

100.8

1102

5198

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

1.7

100.4

1865

10405

KMAK, ,

NOMESCO Finland

1.3

100.4

17600

145483

N05AE04

ATC

ziprasidone; systemic

3.9

100.2

298

717

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.4

100.2

710

2811

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

100.1

1558

8259

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

100.1

1061

4949

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

100.0

1497

7842

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

99.9

942

4203

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

99.7

1001

4575

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.6

99.1

597

2190

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.2

98.8

839

3591

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

98.4

1314

6638

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.6

98.4

2457

14792

E000003, ,

ATC

1.9

98.2

1350

6884

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.6

97.9

583

2126

E87.5

ICD-10 Finland

Hyperkalaemia

2.8

97.9

512

1748

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.4

97.8

694

14293

D01AE15

ATC

terbinafine; topical

1.7

97.8

1988

11363

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

97.5

2136

12449

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.9

97.4

1280

6432

L29

ICPC

Musculoskeletal sympt/complt other

1.6

97.4

2784

17293

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

97.3

3697

24378

H3603, E113,

ICD-10 Finland

4.0

97.1

284

675

A10BB07

ATC

glipizide; oral

4.0

97.1

281

663

Z72.0

ICD-10 Finland

Tobacco use

2.1

97.1

902

4002

SGB30

NOMESCO Finland

Other complicated root filling

1.5

96.9

4031

27048

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.5

96.8

3008

19029

R03BA08

ATC

ciclesonide; inhalant

1.6

96.6

2776

17261

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

96.6

3363

21791

OAB78, ,

SPAT

4.9

96.5

217

419

SPAT1252

SPAT

Overall medication plan or its review

1.7

96.4

1712

9430

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

96.4

3001

18993

SFD11

NOMESCO Finland

Gradual caries removal, at least two tooth surfaces

2.1

96.3

965

4407

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.7

96.3

522

1816

D06AX01

ATC

fusidic acid; topical

1.5

95.8

2851

17867

R06AX22

ATC

ebastine; oral

1.4

95.7

5606

39928

S01

ICPC

Pain/tenderness of skin

1.8

95.6

1471

7769

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

95.3

1110

5353

J01FA01

ATC

erythromycin; systemic

1.4

95.2

4533

31171

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.5

95.0

612

2319

TK800

NOMESCO Finland

Hemodialysis

2.4

94.9

649

2528

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

94.9

3676

24326

D05AX52

ATC

calcipotriol, combinations; topical

1.8

94.8

1651

9043

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

94.8

1716

9503

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.1

94.5

886

3944

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

94.2

1055

5019

Z08

ICPC

Social welfare problem

2.8

94.1

492

1679

K80.8

ICD-10 Finland

Other cholelithiasis

2.6

94.1

585

2179

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

94.0

2220

13182

O80.8

ICD-10 Finland

Other single spontaneous delivery

1.8

93.8

1512

8096

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

93.7

638

2480

A05

ICPC

Feeling ill

1.6

93.7

2058

11998

Z2445

NOMESCO Finland

Psychologist

1.9

93.5

1300

6652

C08CA10

ATC

nilvadipine; oral

2.7

93.2

515

1809

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

93.2

1141

5599

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.9

93.1

1296

6633

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

93.1

830

3623

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.2

92.9

777

3304

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

92.7

1904

10909

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.6

92.7

539

1943

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

92.5

711

2918

Z50.1

ICD-10 Finland

Other physical therapy

1.8

92.2

1496

8025

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

92.0

3206

20764

N06AX22

ATC

agomelatine; oral

2.1

92.0

869

3880

UJD02

NOMESCO Finland

Gastroscopy

1.9

91.8

1294

6650

WVA30, ,

SPAT

1.7

91.8

2007

11687

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

91.7

1434

7609

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

91.4

2275

13678

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

91.4

754

3189

N06AG02

ATC

moclobemide; oral

1.9

91.4

1253

6383

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

91.3

1875

10741

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

91.3

1459

7793

H36.01

ICD-10 Finland

Diabetic maculopathy

2.9

91.2

437

1423

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

91.1

3209

20830

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

90.7

2223

13314

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

90.7

881

3976

B80

ICPC

Iron deficiency anaemia

2.1

90.7

870

3908

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

90.3

3101

20019

C10AB02

ATC

bezafibrate; oral

3.5

90.1

320

870

N05BE01

ATC

buspirone; oral

2.1

89.9

931

4305

R52.0

ICD-10 Finland

Acute pain

1.9

89.9

1114

5489

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.0

89.8

968

4542

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

89.8

2976

19073

RD160, ,

NOMESCO Finland

7.7

89.7

129

159

I20.09

ICD-10 Finland

Unstable angina

1.8

89.5

1310

6811

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.9

89.4

431

1408

C09BA03

ATC

lisinopril and diuretics; oral

2.5

89.3

587

2246

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

3.7

89.1

284

718

D07AB08

ATC

desonide; topical

1.5

89.0

3292

21574

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

7.2

88.7

134

175

A10BD08

ATC

metformin and vildagliptin; systemic

3.9

88.7

269

657

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

88.5

1251

6434

L02

ICPC

Back symptom/complaint

1.5

88.4

3462

22938

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

88.2

1281

6644

S22

ICPC

Nail symptom/complaint

1.6

88.2

2045

12082

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.7

88.1

486

1706

N07BB01

ATC

disulfiram; oral

1.8

88.1

1326

6955

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.9

87.8

428

1407

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

87.8

32676

293626

SPAT1251

SPAT

Organisation of medication

2.1

87.6

916

4251

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.9

87.2

410

1321

WX110, ,

SPAT

1.7

87.1

1848

10675

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

86.8

4727

33217

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.5

86.8

561

2129

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.9

86.7

429

1422

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.4

86.3

593

2316

I11

ICD-10 Finland

Hypertensive heart disease

4.9

86.2

194

375

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.2

86.2

742

3193

N05AH02

ATC

clozapine; systemic

2.4

86.1

611

2421

G04BD08

ATC

solifenacin; oral

1.7

86.0

1636

9180

A11CC03

ATC

alfacalcidol; systemic

2.3

85.9

682

2838

K03.66

ICD-10 Finland

Tooth plaque

1.6

85.8

2393

14765

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

85.6

1410

7597

XA421

NOMESCO Finland

Nocturnal polygraphy

4.0

85.5

245

574

WVA20, ,

SPAT

1.9

85.3

1103

5511

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.9

85.2

1068

5281

NG2AA

NOMESCO Finland

Patella X-ray examination

2.1

85.2

830

3751

WZA00

NOMESCO Finland

Concise certificate

1.6

85.0

2117

12724

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.3

84.9

328

941

JDF21

NOMESCO Finland

Laparoscopic gastric banding

800.6

84.6

R60.1

ICD-10 Finland

Generalized oedema

3.6

84.6

291

775

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

84.6

1355

7240

K86

ICPC

Hypertension uncomplicated

1.4

84.3

3485

23320

E87.6

ICD-10 Finland

Hypokalaemia

2.0

84.1

989

4785

R05

ICD-10 Finland

Cough

1.3

84.1

6754

50339

F31

ICD-10 Finland

Bipolar affective disorder

2.6

83.9

488

1760

AA43B, ,

NOMESCO Finland

22.3

83.8

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

83.7

1978

11738

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.0

83.6

929

4407

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.7

83.4

458

1604

B01AC04

ATC

clopidogrel; oral

1.4

83.3

3760

25563

-1, ,

NOMESCO Finland

1.3

83.3

10964

87037

SPAT1151

SPAT

Treatment of major wounds

3.1

83.3

356

1086

D02AE01

ATC

carbamide; topical

1.6

83.2

1886

11077

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

83.1

606

2430

I25.2

ICD-10 Finland

Old myocardial infarction

1.8

83.0

1296

6872

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

82.7

1552

8675

U07

ICPC

Urine symptom/complaint other

1.5

82.6

2466

15445

IHZ04, ,

SPAT

2.3

82.4

665

2786

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.3

82.3

676

2854

J01FA15

ATC

telithromycin; oral

1.5

82.2

2926

19014

C09DB01

ATC

valsartan and amlodipine; oral

2.0

82.1

943

4525

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.1

82.0

344

1038

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

81.8

1526

8515

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

81.7

1072

5381

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.7

81.6

1542

8634

F32.8

ICD-10 Finland

Other depressive episodes

2.4

81.5

590

2359

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

81.5

1126

5749

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

81.4

1342

7231

R05DA01

ATC

ethylmorphine; oral

1.6

81.3

2167

13228

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.4

81.1

299

833

D01AC03

ATC

econazole; topical

1.7

80.7

1558

8774

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.5

80.6

524

1994

C08CA05

ATC

nifedipine; systemic

1.7

80.5

1491

8302

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

80.2

615

2522

X58

ICD-10 Finland

Exposure to other specified factors

1.4

80.2

4743

33744

K92.1

ICD-10 Finland

Melaena

1.8

80.1

1344

7278

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.0

80.1

955

4643

R04.0

ICD-10 Finland

Epistaxis

1.6

80.0

1910

11358

R73

ICD-10 Finland

Elevated blood glucose level

2.0

80.0

898

4274

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.1

79.9

831

3848

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.4

79.9

567

2247

D09AB01

ATC

zinc bandage without supplements; topical

2.4

79.7

575

2296

O82.0

ICD-10 Finland

Delivery by elective caesarean section

1.7

79.5

1422

7841

SPAT1202

SPAT

Intra-articular injection

2.1

79.5

793

3615

E03

ICD-10 Finland

Other hypothyroidism

1.6

79.5

1858

10992

K91.1

ICD-10 Finland

Postgastric surgery syndromes

10.2

79.0

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

78.6

2214

13684

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

78.5

1937

11609

QXB99, ,

SPAT

2.1

78.5

806

3714

SPAT1360

SPAT

Extensive global examination

1.6

78.5

1878

11174

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

78.4

908

4369

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.4

78.4

581

2347

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

2.5

78.0

487

1818

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

78.0

1634

9403

M54.3

ICD-10 Finland

Sciatica

1.6

77.9

1759

10317

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

77.6

1805

10664

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.9

77.6

1000

4990

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.4

77.2

559

2235

S02CA02

ATC

flumetasone and antiinfectives; otic

1.7

77.1

1452

8122

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

77.0

928

4527

R06AX13

ATC

loratadine; oral

1.4

76.8

4773

34199

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

76.8

1637

9462

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

76.6

1227

6554

J01

ICD-10 Finland

Acute sinusitis

1.6

76.5

1912

11495

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

76.3

1079

5548

F33

ICD-10 Finland

Recurrent depressive disorder

2.0

76.3

885

4262

R07.3

ICD-10 Finland

Other chest pain

1.5

76.2

3003

19893

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.1

76.1

765

3497

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

76.1

896

4336

OAB76, ,

SPAT

2.3

76.1

582

2384

NHQ40

NOMESCO Finland

Amputation of toe

2.7

76.1

424

1497

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.9

75.9

962

4774

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.7

75.9

427

1515

R03BB01

ATC

ipratropium bromide; inhalant

2.1

75.8

785

3629

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

75.7

707

3143

S06

ICPC

Rash localized

1.7

75.7

1619

9366

N03AE01

ATC

clonazepam; systemic

1.7

75.7

1582

9098

R03AK11

ATC

formoterol and fluticasone; inhalant

2.1

75.5

758

3465

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.1

75.3

699

3100

N07BA03

ATC

varenicline; oral

1.7

75.3

1566

8994

D91

ICPC

Abdominal hernia other

2.7

75.1

401

1385

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

75.1

2235

13980

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

75.1

1026

5219

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.2

75.0

648

2793

RD130, ,

NOMESCO Finland

19.2

75.0

T45

ICPC

Metabolic, Observ/health educat/advice/diet

2.6

74.6

427

1528

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.4

74.6

3189

21446

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

74.3

798

3738

EMB10

NOMESCO Finland

Tonsillectomy

1.6

74.3

1936

11752

M54.8

ICD-10 Finland

Other dorsalgia

1.7

74.0

1471

8347

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.5

74.0

256

685

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.6

73.9

250

659

104

Kela drug reimbursment

Thyroid insufficiency

1.6

73.7

1894

11460

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

73.6

956

4782

SPAT1285

SPAT

Provision of consultation response

1.7

73.4

1433

8092

R09

ICPC

Sinus symptom/complaint

1.5

73.3

2773

18221

ZX120

NOMESCO Finland

Intravenous

1.5

73.2

2558

16545

L01

ICPC

Neck symptom/complaint

1.3

73.1

5293

38780

L11

ICPC

Wrist symptom/complaint

1.4

73.0

2999

20017

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

72.9

2269

14327

F33.8

ICD-10 Finland

Other recurrent depressive disorders

2.8

72.6

361

1200

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.9

72.6

990

5031

C10AA04

ATC

fluvastatin; oral

1.6

72.6

1855

11207

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.4

72.1

487

1887

T78.4

ICD-10 Finland

Allergy, unspecified

1.7

72.1

1500

8614

N06AX18

ATC

reboxetine; oral

2.8

72.0

368

1242

WX780, ,

SPAT

3.3

72.0

282

817

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.2

72.0

656

2889

H60

ICD-10 Finland

Otitis externa

1.6

71.9

1735

10338

D09

ICPC

Nausea

1.6

71.9

1557

9032

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.7

71.9

1316

7302

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.2

71.9

193

431

UKC02

NOMESCO Finland

Cystoscopy

1.4

71.7

3821

26689

K80

ICD-10 Finland

Cholelithiasis

2.4

71.7

500

1966

K28

ICPC

Limited function/disability (K)

2.3

71.7

535

2168

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.4

71.7

503

1984

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4153

20975

1.97

323.31

4.6

4.0

102.30

85.06

ng/l

19.42

3645

18453

(3026782) Osmolality of Urine

8694

55135

1.63

309.49

3.4

2.8

546.64

529.03

mosm/kgh2o

8.75

7721

48316

(3000991) Gas panel - Venous blood

4589

24306

1.89

308.93

11.3

9.3

—

(3030467) Casts [#/volume] in Urine by Automated count

12127

83187

1.55

308.68

3.7

3.2

0.48

0.37

e6/l

4.47

9022

59957

(3009261) Glucose [Presence] in Urine by Test strip

22016

169519

1.54

307.65

4.6

3.7

0.49

0.18

estimate

0.49

4600

33153

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

15383

105845

1.63

307.65

4.0

3.3

1.34

2.01

e6/l

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17634

104648

2.11

307.65

3.5

3.3

31.97

32.65

u/l

0.69

16634

99229

(3019198) Lymphocytes [#/volume] in Blood

22149

163708

1.68

307.65

7.2

6.5

2.03

1.93

e9/l

16.97

19733

145447

(3018010) Neutrophils/Leukocytes in Blood

20170

148490

1.61

307.65

7.1

6.4

58.61

56.71

117.08

19380

142488

(3036481) Cortisol [Moles/volume] in Serum or Plasma

6408

29238

2.28

307.65

2.2

2.3

341.76

383.53

nmol/l

53.29

5882

27363

(3012544) pH of Venous blood

5476

27559

2.02

307.65

4.8

4.0

7.37

7.38

4.33

3253

15528

(3033658) Prothrombin time (PT) actual/Normal

11592

76644

1.61

307.65

4.7

4.1

92.38

92.01

0.82

11283

74870

(3013115) Eosinophils [#/volume] in Blood

22375

165126

1.69

307.65

7.5

6.6

0.21

0.19

e9/l

6.54

19798

145592

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

15118

96318

1.80

307.65

3.0

2.7

53.15

69.53

u/l

1.86

14107

89586

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

31048

244727

2.18

307.65

5.7

4.4

14.61

14.60

pmol/l

0.08

29253

227644

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2783

8860

3.11

307.65

3.2

2.8

25.12

24.52

mmol/l

11.20

2745

8690

(3003129) Base excess in Capillary blood by calculation

1138

2861

3.83

307.65

2.0

2.2

0.75

0.41

mmol/l

2.18

1098

2728

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11466

75256

1.63

307.65

2.5

2.3

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

28198

228313

1.67

307.65

5.2

4.3

15.37

10.60

mm/h

307.65

26682

215407

(3037467) Urinalysis macro (dipstick) panel - Urine

27098

211736

1.75

307.65

5.4

4.4

1.76

4.09

0.73

291

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

27439

218213

1.70

307.65

4.4

3.2

55.43

43.08

u/l

78.85

26094

207439

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1716

5468

3.05

307.65

2.5

2.4

142.59

96.49

ug/min

2.96

1063

3302

(3002032) Base excess in Venous blood by calculation

5273

26512

2.02

307.65

4.9

4.0

2.01

1.70

mmol/l

6.65

4673

23397

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7899

45885

1.79

307.65

2.1

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

14278

74580

2.30

307.65

3.7

3.0

1171.33

1142.21

ng/l

0.34

11949

63500

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5605

27178

2.11

307.65

2.3

2.4

0.22

g/l

0.28

5242

25496

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

20539

146623

1.71

307.65

3.1

2.7

—

estimate

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

23486

178316

1.65

307.65

10.1

9.7

4.58

4.01

e9/l

255.26

20516

155548

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

33207

283396

1.96

307.65

5.4

4.0

1.59

1.25

mmol/l

307.65

31284

265604

(3001604) Monocytes [#/volume] in Blood

21796

159725

1.69

307.65

7.1

6.4

0.60

0.57

e9/l

74.13

18975

138749

(3019309) Folate [Moles/volume] in Red Blood Cells

8686

42390

2.21

307.65

2.0

1.7

1201.10

1155.45

nmol/l

4.64

7055

32340

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1182

2954

3.86

307.65

1.2

25.60

37.70

nmol/l

1.11

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

13847

76653

2.12

307.65

2.8

2.3

3.06

2.67

mg/l

63.52

12398

66349

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9025

46106

2.11

307.65

3.1

2.5

2.47

2.36

g/l

68.72

8382

42727

(3021601) Nitrite [Presence] in Urine by Test strip

21710

166488

1.55

307.65

4.6

3.6

0.00

estimate

0.02

4988

34057

(3026493) Urate [Moles/volume] in Serum or Plasma

14799

76732

2.35

307.65

3.0

2.6

361.55

328.60

umol/l

259.71

13198

68815

(3031040) Bacteria [#/volume] in Urine by Automated count

25786

201834

1.66

307.65

5.6

4.4

1633.42

1636.17

e6/l

0.00

446

2492

(3032080) INR in Blood by Coagulation assay

19964

127951

2.01

307.65

16.4

12.2

1.23

1.20

inr

14.05

16626

106389

(3013512) EKG study

13917

94733

1.61

307.65

4.4

3.3

0.67

0.75

0.37

228

(3024354) Oxygen [Partial pressure] in Venous blood

4504

22601

2.00

307.65

4.1

3.3

4.73

4.59

kpa

4.55

4385

22023

(3016244) Insulin [Units/volume] in Serum or Plasma

1383

1458

9.23

307.65

3.9

2.6

38.20

16.36

mu/l

50.53

1334

1351

(3018418) pH of Serum or Plasma

13260

86508

1.69

307.65

5.0

4.3

7.40

0.28

9276

61209

(3020682) Albumin/Creatinine [Ratio] in Urine

18212

88361

2.84

307.65

5.1

4.1

11.11

8.23

mg/mmol

10.51

12676

53965

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5008

16774

3.09

307.65

3.9

3.5

5.28

5.09

kpa

41.58

4821

16023

(3035350) Ketones [Presence] in Urine by Test strip

21922

168338

1.55

307.65

4.6

3.7

4.49

4.06

estimate

0.14

5063

34611

(3019069) Monocytes/Leukocytes in Blood

20091

146807

1.63

307.65

7.3

6.7

8.32

8.72

87.61

19025

138518

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

34058

287362

2.38

307.65

7.0

4.6

6.37

5.79

mmol/l

307.65

32223

268245

(3022948) Iron [Moles/volume] in Serum or Plasma

9599

49818

2.10

307.65

3.1

2.5

12.58

14.17

umol/l

3.91

9008

46671

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2753

8873

3.07

307.65

3.8

24.87

24.74

mmol/l

1.70

2581

8198

(3009508) Creatinine [Moles/volume] in Urine

19005

97562

2.70

307.65

4.1

3.4

7.94

7.71

mmol/l

8.64

16383

83761

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6056

31286

1.98

307.65

9.4

8.0

5.33

5.05

kpa

71.27

5854

30171

(3007853) Bacteria identified in Skin by Aerobe culture

7103

35178

2.11

307.65

2.0

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

21854

144276

2.03

307.65

8.9

7.0

1.21

mmol/l

27.75

19375

124993

(3003396) Base excess in Arterial blood by calculation

6034

31023

1.99

307.65

9.4

8.0

1.30

0.80

mmol/l

15.71

5112

25582

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9919

47182

2.33

307.65

3.3

3.7

0.82

mmol/l

0.04

9459

44524

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8355

42018

2.12

307.65

3.1

2.6

20.79

23.48

67.17

7805

39165

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

23324

156224

2.09

307.65

6.3

6.6

10.65

11.09

umol/l

6.36

22296

148689

(3042936) Bacteria identified in Isolate by Culture

7667

41413

1.93

307.65

2.4

2.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

19631

128715

1.92

307.65

8.3

6.5

1.21

mmol/l

18.08

18472

119708

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

15934

106541

1.71

307.65

4.6

3.3

44.74

60.53

ng/l

1.23

10703

66292

(3009343) pH of Capillary blood

4887

16265

3.10

307.65

3.9

3.5

7.41

7.42

17.12

4078

13534

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

34077

285630

2.48

307.65

7.2

5.3

1.86

1.84

mu/l

1.62

32464

268284

(3023103) Potassium [Moles/volume] in Serum or Plasma

35156

304661

2.59

307.65

26.7

16.0

3.97

3.95

mmol/l

41.96

34762

298215

(3013826) Glucose [Moles/volume] in Serum or Plasma

26077

173672

2.38

307.65

6.7

4.8

7.11

6.53

mmol/l

253.31

24790

162757

(3019550) Sodium [Moles/volume] in Serum or Plasma

35135

304027

2.61

307.65

26.4

15.9

139.72

139.66

mmol/l

4.49

34770

298130

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10325

58378

1.92

307.65

2.1

1.6

30318720.68

37981936.31

pmol/l

0.67

8922

49403

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4266

14177

3.07

307.65

3.7

3.4

1.87

1.60

mmol/l

4.19

3216

10293

(3002582) Erythrocytes [#/volume] in Urine

13965

96265

1.58

307.65

3.8

3.3

68.71

75.37

e6/l

0.24

10774

72564

(3020779) Urea [Moles/volume] in Serum or Plasma

4924

24279

2.05

307.65

9.5

7.9

10.97

8.97

mmol/l

58.34

4730

23312

(3022096) Basophils/Leukocytes in Blood

20056

146400

1.63

307.65

7.3

6.7

0.64

0.69

39.77

18944

137810

(3003458) Phosphate [Moles/volume] in Serum or Plasma

8716

35561

2.71

307.65

6.5

6.3

1.08

1.03

mmol/l

40.45

8311

33137

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

11796

68657

1.90

307.65

2.0

1.8

1.05

1.14

mg/l

2.31

9393

52629

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

34358

280207

3.04

307.65

10.1

5.5

41.99

38.24

mmol/mol

307.65

33075

264852

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

20672

126766

2.20

307.65

2.7

2.0

95.19

97.45

pmol/l

10.31

12610

67324

(3023368) Bacteria identified in Blood by Culture

13021

75445

1.96

307.65

5.0

4.2

—

(3019977) pH of Arterial blood

6051

31334

1.98

307.65

9.5

8.0

7.41

7.42

22.07

3365

16714

(3006315) Basophils [#/volume] in Blood

21849

160076

1.69

307.65

7.1

6.5

0.04

e9/l

5.97

19010

138973

(3006504) Eosinophils/Leukocytes in Blood

20039

146455

1.62

307.65

7.2

6.6

2.77

2.83

3.98

18964

138031

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5423

27207

2.03

307.65

4.8

4.0

5.96

5.80

kpa

23.07

5296

26574

(3024561) Albumin [Mass/volume] in Serum or Plasma

21718

128777

2.41

307.65

5.8

5.0

35.64

36.23

g/l

49.64

20726

121013

(3015736) pH of Urine

18080

134207

1.52

307.65

4.0

3.3

6.13

6.22

25.76

10077

75522

(3016502) Oxygen saturation in Arterial blood

5424

27791

1.98

307.65

9.7

8.4

94.80

95.96

36.98

5274

26832

(3015377) Calcium [Moles/volume] in Serum or Plasma

15108

101449

1.68

307.65

3.2

3.5

2.34

2.35

mmol/l

15.82

13815

93203

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1789

5332

3.27

307.65

1.9

2.4

1.07

0.82

nmol/l

28.84

1466

4587

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

30384

230396

2.32

307.65

9.3

8.1

81.89

76.85

u/l

61.96

29283

219419

(3018095) Leukocytes [#/volume] in Urine

15787

113411

1.54

307.65

4.6

3.8

87.01

82.38

e6/l

0.32

11282

77610

(3021960) Folate [Moles/volume] in Serum or Plasma

13818

79271

2.02

307.65

2.0

1.6

19.87

20.15

nmol/l

1.38

12240

68252

(3012516) Albumin [Mass/volume] in Urine

17826

87112

2.78

307.65

4.1

3.5

64.72

46.51

mg/l

14.60

12712

54164

(3027801) Oxygen [Partial pressure] in Arterial blood

6054

31270

1.98

307.65

9.4

8.0

11.12

13.01

kpa

182.67

5836

30149

(3002030) Lymphocytes/Leukocytes in Blood

20460

151153

1.61

307.65

7.2

6.5

27.20

28.62

75.54

19561

143995

(40768797) Stomach Pathology biopsy report

7038

41420

1.74

307.65

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

21350

139466

2.04

307.65

3.3

2.4

70.53

714.71

nmol/l

0.51

19957

128560

(3001122) Ferritin [Mass/volume] in Serum or Plasma

22536

158911

1.85

307.65

4.3

3.1

107.67

109.94

ug/l

0.83

21331

150114

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

34828

304451

2.22

300.92

22.6

14.2

21.60

22.90

mg/l

13.45

32257

246005

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4851

26396

1.84

299.16

10.6

8.8

124.20

121.38

g/l

16.41

4778

25779

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

990

2600

3.65

293.79

1.5

1.3

1.68

1.39

nmol/l

11.03

910

2342

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

12692

88903

1.52

288.46

2.4

2.2

194.76

199.96

u/l

0.25

12050

84398

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5805

33701

1.74

286.21

2.0

1.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6774

41037

1.68

285.33

2.0

1.8

1.45

1.43

2.31

5958

36572

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3314

16164

2.02

282.84

11.5

10.2

24.67

24.19

mmol/l

12.19

3229

15864

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

34646

303230

2.11

281.31

7.2

5.3

2.61

2.77

mmol/l

234.82

33015

286415

(3014111) Lactate [Moles/volume] in Serum or Plasma

4621

25264

1.82

279.17

9.8

7.9

1.40

1.32

mmol/l

5.76

4530

24822

(3028626) Oxygen [Partial pressure] in Capillary blood

1761

6698

2.55

273.15

3.7

3.2

8.28

8.48

kpa

5.70

1736

6525

(3044889) 12 lead EKG panel

25519

207232

1.51

270.69

4.6

3.7

3357.81

3101.78

0.02

384

(4146454) Self-monitoring of blood glucose

922

2439

3.62

270.57

2.8

—

(3021901) Oxygen saturation in Capillary blood

1511

5351

2.73

270.47

3.7

2.9

90.32

90.77

1.85

1488

5199

(3021589) Normoblasts [#/volume] in Blood

18342

139586

1.47

270.42

14.0

10.8

0.00

e9/l

1.80

14997

114098

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5961

35408

1.70

268.64

2.7

2.8

7.80

8.04

umol/l

0.36

5085

30810

(3000850) Epithelial cells [#/volume] in Urine

9794

65657

1.55

268.29

3.1

2.7

7.49

5.89

e6/l

20.65

8955

59604

(3004119) Hemoglobin [Mass/volume] in Venous blood

3317

16552

1.97

264.52

4.2

3.3

130.57

129.88

g/l

0.94

3227

16114

(3037522) Nuclear Ab [Titer] in Serum

7463

47111

1.61

264.44

1.4

469.52

534.32

titre

2.35

1447

9853

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1378

4740

2.80

260.64

1.1

42.65

2827.40

iu/ml

0.67

288

998

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

34294

300147

1.97

260.33

6.4

4.7

4.42

4.71

mmol/l

307.65

32769

284605

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

33462

290572

1.84

260.23

20.8

13.5

85.85

85.26

ml/min/173m2

4.76

31524

266193

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

34162

298628

1.95

259.90

6.3

4.6

1.27

1.49

mmol/l

307.65

32488

281852

(3027273) Bicarbonate [Moles/volume] in Venous blood

2518

11440

2.15

258.90

4.2

3.4

25.45

25.22

mmol/l

2.57

2453

11042

(36304419) Bacteria [Presence] in Urine

11411

79849

1.50

252.15

3.6

3.1

12.05

162.34

estimate

0.80

284

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5416

31876

1.70

250.91

2.0

1.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2713

12885

2.06

247.81

5.2

3.8

49.24

48.33

1.06

2676

12715

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2834

13721

2.02

245.44

1.7

1.8

0.28

0.31

mg/l

2.86

1229

6570

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16919

128528

1.44

240.64

2.1

1.9

1.65

1.33

mmol/l

241.54

14274

109910

(3029937) Albumin [Presence] in Urine by Test strip

12490

90283

1.45

228.37

4.8

3.8

0.00

estimate

0.55

4561

31968

(3027945) Reticulocytes/Erythrocytes in Blood

5205

31095

1.67

225.75

2.6

1.97

1.74

42.66

4636

27950

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3504

18877

1.82

218.79

9.7

8.3

25.19

24.70

mmol/l

10.45

3475

18751

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

288

322

8.47

216.71

1.0

71.68

90.32

ug/l

7.77

254

235

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3362

17983

1.83

214.65

12.1

10.1

1.42

1.32

5.43

3338

17889

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3278

17424

1.84

213.51

12.4

10.4

0.61

0.65

4.94

3256

17342

(3014007) Fractional oxyhemoglobin in Arterial blood

3355

18078

1.82

208.85

12.3

10.2

93.22

94.18

17.84

3344

18022

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

8468

57597

1.50

206.85

1.4

1.3

8.79

10.40

u/ml

1.59

3336

23306

(3034770) Mitochondria Ab [Titer] in Serum

1949

8736

2.16

206.17

1.2

1.3

886.82

960.83

titre

0.17

254

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3715

20735

1.76

205.16

1.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2777

14193

1.91

204.04

3.8

3.1

1.41

1.27

7.86

2765

14129

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2750

14076

1.91

201.03

3.8

3.1

0.62

0.13

2740

14035

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3100

16520

1.84

199.64

5.1

4.3

24.34

24.20

mmol/l

1.51

3055

16345

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3501

19360

1.77

199.32

3.1

2.8

159.82

171.02

ng/l

1.01

3103

17682

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8247

56161

1.49

199.00

2.7

2.9

2.45

2.44

mmol/l

4.83

7271

50545

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

9034

62692

1.47

198.08

1.4

1.3

32.85

31.90

iu/ml

0.13

2445

19106

(1616796) Gas panel - Central venous blood

1490

6074

2.36

197.77

5.1

3.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

1955

8917

2.12

197.55

1.2

1.3

123.95

119.00

titre

0.10

185

877

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2138

10142

2.04

194.48

2.2

2.0

2.05

2.12

ug/l

0.09

1905

9050

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

3992

23067

1.70

194.08

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

592

1471

3.83

190.07

1.9

1.5

1.60

1.18

nmol/l

11.19

445

1129

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3047

16422

1.81

188.63

8.3

6.8

25.04

24.42

mmol/l

13.14

2946

15714

(3007164) IgA [Mass/volume] in Serum or Plasma

9657

68476

1.44

186.98

1.5

2.58

2.29

g/l

33.09

6037

43763

(3020891) Body temperature

2443

12370

1.92

183.96

5.4

4.6

36.94

36.91

°c

4.26

2412

12266

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2968

16063

1.80

180.89

1.9

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3740

21709

1.69

177.82

3.3

3.6

4.48

4.54

pmol/l

3.33

3344

19718

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10901

79577

1.41

177.46

1.4

1.3

1.45

1.59

u/ml

0.65

3053

22522

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7079

47697

1.49

176.96

3.3

3.0

4.99

2.94

e6/l

8.97

3429

22610

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7621

52134

1.47

176.44

3.2

2.9

1.33

1.09

e6/l

2.49

3978

27147

(3020630) Protein [Mass/volume] in Serum or Plasma

3824

22440

1.67

174.25

2.1

2.7

66.73

66.54

g/l

0.85

3537

20771

(3000494) Fungus identified in Specimen by Culture

5810

37696

1.53

173.57

1.5

—

(3019225) pH of Specimen

4281

25878

1.63

173.56

4.5

4.1

7.36

2.12

3332

18410

(3009214) Lutropin [Units/volume] in Serum or Plasma

2215

11080

1.94

172.64

1.5

1.4

8.77

10.50

u/l

9.92

1806

8969

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1770

8174

2.09

172.63

3.3

0.34

0.35

iu/ml

0.32

975

4438

(3028026) IgM [Mass/volume] in Serum or Plasma

3331

18881

1.72

172.55

1.7

2.0

1.16

1.32

g/l

8.67

3078

17505

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5304

33774

1.56

172.39

5.8

4.5

29.75

32.57

74.08

4093

23290

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8902

63056

1.43

170.34

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2390

12334

1.88

169.35

2.0

1.6

5.34

4.00

mg/l

5.58

2256

8639

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

16223

127156

1.36

167.61

4.6

3.5

0.47

0.40

estimate

0.10

4137

28223

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7833

54418

1.45

165.74

4.3

3.6

301.39

489.64

ng/l

3.65

5663

38855

(3005719) IgG [Mass/volume] in Serum or Plasma

4061

24574

1.62

163.25

2.5

2.9

10.65

10.53

g/l

0.96

3744

22818

(3021387) Prolactin [Units/volume] in Serum or Plasma

2679

14579

1.79

159.47

1.7

304.52

307.20

mu/l

0.14

2420

13189

(3017143) Hepatitis C virus Ab [Presence] in Serum

6295

42211

1.49

158.99

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5111

32850

1.54

157.97

3.6

4.6

234.23

240.03

u/l

2.17

4850

31368

(3023520) Reticulocytes [#/volume] in Blood

3917

23680

1.62

157.72

2.6

2.7

79.76

68.98

e9/l

50.55

2859

17214

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4649

29440

1.56

153.28

2.7

2.6

50.79

45.32

u/l

0.20

3822

25126

(3018405) Lactate [Moles/volume] in Arterial blood

1731

8302

2.01

151.89

4.6

4.2

1.42

1.38

mmol/l

0.83

1695

8143

(3020564) Creatinine [Moles/volume] in Serum or Plasma

35631

322093

2.00

150.19

28.3

17.7

78.20

74.12

umol/l

54.45

35392

318756

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

35537

321121

1.95

147.27

15.7

11.3

30.31

25.90

u/l

217.79

34953

313206

(3010421) pH of Blood

1767

8671

1.96

145.11

5.2

3.3

7.41

3.55

1741

8558

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1450

6647

2.10

143.78

2.8

2.2

131.20

131.00

g/l

0.11

1132

5113

(3013139) Helicobacter pylori Ag [Presence] in Stool

3650

22293

1.60

139.83

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3610

22082

1.60

137.28

4.9

3.8

1.22

1.23

mmol/l

16.33

3184

19056

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4347

27790

1.53

136.02

4.1

3.1

—

(3008037) Lactate [Moles/volume] in Venous blood

1313

5918

2.13

136.00

4.0

2.9

1.63

1.52

mmol/l

3.25

1286

5767

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2294

12484

1.78

135.81

1.5

1.7

17.82

14.85

u/ml

1.03

392

3353

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1073

4468

2.30

135.08

1.8

1.6

401.81

378.20

mu/l

0.65

862

3634

(3021440) Promyelocytes/Leukocytes in Blood

4104

26042

1.54

132.62

4.8

4.5

0.10

0.13

1.85

1183

6663

(3017181) Myelocytes/Leukocytes in Blood

4252

27204

1.53

132.29

4.7

4.5

0.88

0.95

0.79

1327

7798

(3004588) Protein electrophoresis panel - Serum or Plasma

3013

17798

1.65

131.84

1.9

2.5

—

2.00

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

10124

75827

1.35

131.74

4.3

3.6

0.15

0.34

1.17

606

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

508

1458

3.31

131.27

1.7

1.6

3.92

8.74

nmol/l

0.63

405

1213

(3027315) Oxygen [Partial pressure] in Blood

1253

5631

2.13

130.72

5.5

3.6

8.58

8.80

kpa

4.51

1225

5509

(3013290) Carbon dioxide [Partial pressure] in Blood

1246

5596

2.13

130.20

5.5

3.6

5.19

4.96

kpa

18.07

1218

5475

(3012501) Base excess in Blood by calculation

1245

5595

2.13

129.88

5.5

3.6

3.00

2.34

mmol/l

9.24

867

3682

(3011985) Renin [Units/volume] in Plasma

1048

4410

2.27

128.66

1.6

81.37

61.91

mu/l

1.66

945

3978

(3002179) Metamyelocytes/Leukocytes in Blood

4070

25966

1.53

127.99

4.4

4.3

0.64

0.72

1.37

1273

7473

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1595

7903

1.94

127.02

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6335

44150

1.42

126.99

2.2

29.97

29.43

9.07

6159

42967

(40758558) Short blood count panel - Blood

12073

93195

1.32

126.77

6.7

6.4

—

(3038515) Glucose [Moles/volume] in Venous blood

1108

4813

2.20

125.92

4.2

3.0

7.93

7.38

mmol/l

6.36

1082

4700

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2192

12034

1.76

125.62

5.8

4.8

1.73

1.64

2.60

2113

11384

(40761511) CBC panel - Blood by Automated count

34940

315470

1.71

124.96

20.1

12.5

—

70.05

—

(40767503) Oxygen content in Capillary blood by calculation

1236

5644

2.10

123.61

3.5

2.5

16.55

16.73

1.20

1213

5520

(3037121) Protein [Mass/volume] in Urine

1807

9416

1.85

123.18

3.1

3.4

427.74

459.73

mg/l

0.24

890

4368

(3025159) Blasts/Leukocytes in Blood

4100

26475

1.51

121.40

5.0

4.7

0.09

0.30

3.75

1113

6490

(3020911) Cortisol [Moles/time] in 24 hour Urine

403

1055

3.62

120.03

1.4

137.79

201.91

nmol/24h

0.52

403

1055

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

618

2110

2.79

118.07

1.3

5.52

5.17

umol/l

1.30

562

1876

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2235

12574

1.72

117.16

1.5

1.6

10.60

13.11

iu/ml

0.52

329

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2224

12499

1.72

117.03

1.8

1.66

1.48

g/l

15.56

1926

10842

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2715

16147

1.63

114.95

12.8

10.0

16.15

16.13

0.14

2647

15581

(3045414) Leukocytes [Presence] in Urine

4424

29318

1.48

114.86

2.2

2.0

0.01

0.03

estimate

1.72

957

6206

(3007930) Methemoglobin/Hemoglobin.total in Blood

1991

10930

1.75

113.82

6.2

5.1

0.84

0.89

5.76

1917

10315

(3005322) IgE [Units/volume] in Serum or Plasma

3615

23036

1.53

113.42

1.4

1.3

248.74

227.06

u/ml

0.43

3416

21496

(3023183) Ammonium ion [Moles/volume] in Plasma

1273

6075

2.01

112.80

3.4

2.8

35.92

33.62

umol/l

2.39

1169

5530

(3043409) Potassium [Moles/volume] in Arterial blood

1413

6993

1.94

112.73

5.1

4.5

3.90

3.86

mmol/l

2.70

1398

6939

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3695

23702

1.52

112.33

2.7

2.4

0.47

0.37

e6/l

1.81

3533

22550

(3041096) Erythrocytes [Presence] in Urine by Automated

11910

93094

1.30

109.92

4.0

3.0

0.34

0.17

estimate

0.64

4064

27645

(3017732) Neutrophils [#/volume] in Blood

5720

40094

1.40

109.01

3.3

3.1

4.77

4.39

e9/l

3.29

4950

35172

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

945

4082

2.21

108.80

1.4

442.49

363.57

pmol/l

0.32

831

3513

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1239

5936

2.00

108.54

1.4

1.3

17.51

27.31

u/l

32.14

999

4898

(3028717) Thiamine [Mass/volume] in Blood

202

332

5.75

107.23

1.4

1.1

61.87

63.62

ug/l

0.54

202

332

(3003694) ABO and Rh group [Type] in Blood

12420

97871

1.29

106.93

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

797

3245

2.34

105.60

2.6

1.70

1.23

g/24h

4.34

491

1959

(3024666) Lithium [Moles/volume] in Serum or Plasma

559

1932

2.75

104.37

14.8

13.0

0.61

0.62

mmol/l

0.83

514

1785

(1761482) Bacteria [#/volume] in Urine by Culture

1201

5782

1.99

103.73

4.4

3.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

9715

74381

1.31

103.04

2.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1924

10795

1.71

101.49

2.1

2.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

906

3959

2.18

101.34

3.4

3.2

0.79

0.81

nmol/l

0.40

743

3127

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1928

10835

1.71

101.09

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

793

3314

2.28

98.87

1.1

—

(3004775) Volume in Urine collected for unspecified duration

517

1769

2.77

98.41

2.4

727.50

658.24

2.48

355

1261

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2872

17954

1.55

97.63

2.6

2.3

5553.82

6265.27

u/l

0.65

1114

7352

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

654

2532

2.46

96.94

2.0

2.4

18.50

19.39

nmol/l

1.65

609

2426

(3023323) Follitropin [Units/volume] in Serum or Plasma

3365

21813

1.50

96.41

1.4

19.55

26.93

iu/l

49.13

2813

18792

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2263

13444

1.62

95.63

2.2

2.1

39.28

39.78

u/l

0.53

2012

12173

(3045424) Erythrocytes [Presence] in Urine

2467

14968

1.59

95.51

2.2

2.1

0.45

0.07

estimate

0.56

752

5007

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1429

7492

1.83

95.11

1.5

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1514

8084

1.79

94.86

2.0

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1762

9841

1.72

94.36

2.0

1.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1788

10034

1.71

94.09

2.3

567.49

526.59

ug/l

0.11

1691

9422

(3014051) Protein [Presence] in Urine by Test strip

11776

93284

1.27

93.89

3.3

2.8

0.08

0.06

0.33

261

1636

(3040151) Glucose [Moles/volume] in Capillary blood

736

3049

2.30

93.67

9.8

6.7

8.27

7.08

mmol/l

3.93

615

2518

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1601

8723

1.76

93.60

2.3

3.6

44.56

40.75

mg/l

0.53

1306

7453

(3034860) Kappa light chains.free [Mass/volume] in Serum

1602

8735

1.76

93.41

2.3

3.6

53.54

58.64

mg/l

0.28

1314

7461

(3033705) Calcium.ionized [Moles/volume] in Venous blood

630

2442

2.45

93.14

2.8

2.2

1.20

mmol/l

0.05

625

2421

(3035285) Chloride [Moles/volume] in Venous blood

638

2491

2.43

92.85

2.8

2.2

105.83

105.68

mmol/l

0.35

633

2470

(3041354) Potassium [Moles/volume] in Venous blood

638

2492

2.43

92.77

2.8

2.2

4.06

4.02

mmol/l

1.12

633

2471

(3024928) Oxygen saturation in Venous blood

1363

7097

1.84

92.73

4.1

3.4

65.38

62.26

5.93

1309

6873

(3019150) Specific gravity of Urine by Refractometry

9539

73880

1.29

90.21

4.7

3.7

1.18

1.12

kg/l

0.14

6285

48468

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1523

8300

1.76

88.90

1.5

14.01

13.45

iu/ml

0.04

184

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3253

21289

1.48

88.49

2.4

2.2

6.19

7.78

ug/l

3.73

2786

18897

(3000492) Spirometry study

4692

32844

1.39

88.31

1.5

—

17.06

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

168

281

5.65

87.63

2.1

1.6

1.32

1.35

umol/l

0.62

155

183

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

965

4563

2.02

87.60

1.2

1.3

31.59

31.67

u/l

0.01

823

3999

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3811

25789

1.44

86.90

1.3

1.2

129.75

143.62

u/ml

1.31

1366

10007

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1131

5672

1.90

86.50

1.9

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

6201

45544

1.34

85.70

2.4

2.5

139.91

121.72

ug/g

3.97

5003

36261

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1426

7711

1.77

85.47

2.2

3.5

2.02

4.33

ratio

3.27

767

4351

(3000330) Specific gravity of Urine by Test strip

2281

13941

1.57

85.27

3.7

3.1

1.02

ratio

21.03

2061

12402

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1737

10001

1.67

82.82

2.0

1.8

32.58

43.69

nmol/l

60.37

1687

9806

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

228

519

4.15

82.73

1.5

5.68

5.60

nmol/l

0.11

217

499

(3028707) Methadone [Presence] in Urine by Screen method

1280

6770

1.81

82.65

2.5

2.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1321

7062

1.79

82.29

1.7

1.6

13688.76

12717.65

e6/l

0.29

908

5064

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

914

4362

2.00

80.83

1.1

1.50

g/l

0.17

829

4027

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1052

5278

1.90

80.32

1.3

1.2

148.92

334.56

titre

3.74

379

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

811

3722

2.07

79.87

7.2

6.3

11.50

11.55

mg/l

0.12

754

3466

(3001186) Copper [Moles/volume] in Serum or Plasma

287

789

3.44

79.53

1.7

1.2

17.34

16.55

umol/l

1.78

256

672

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1058

5337

1.89

79.45

1.3

1.2

101.25

137.32

titre

0.33

112

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1839

10880

1.62

78.65

1.8

2.4

3.98

3.67

g/l

17.41

1705

10029

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1840

10894

1.62

78.46

1.8

2.4

4.42

4.20

g/l

21.94

1706

10047

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1842

10912

1.62

78.36

1.8

2.4

7.79

7.25

g/l

34.17

1704

10053

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1581

9021

1.68

77.95

1.4

282.84

278.04

ug/g

0.38

875

5142

(3017569) Oxygen content in Arterial blood

390

1311

2.82

76.84

2.3

2.2

16.35

15.95

1.52

390

1311

(3025941) Bacteria identified in Stool by Culture

2778

18140

1.48

75.88

1.3

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

901

4403

1.95

74.42

1.3

0.19

0.23

nmol/l

0.38

275

(3028271) Lactate [Moles/volume] in Capillary blood

859

4175

1.96

72.08

2.4

1.8

1.73

1.72

mmol/l

0.04

839

4057

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1722

10254

1.61

71.59

1.6

1.9

0.26

0.23

g/l

47.87

1650

9795

(3016750) Collection duration of Urine

388

1351

2.72

71.54

2.2

2.3

495.66

500.19

min

0.38

282

1047

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

882

4354

1.93

70.70

1.3

1.04

1.59

nmol/l

0.36

853

4200

(3022145) Colonoscopy Study observation

4943

36050

1.33

70.16

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1576

9230

1.63

70.09

3.6

3.7

1.82

1.43

mg/l

44.41

1443

8537

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

715

3290

2.07

69.94

1.4

9.33

7.91

mmol/l

13.03

672

3164

(3020717) Zinc [Moles/volume] in Serum or Plasma

467

1803

2.46

69.73

1.7

1.4

16.36

25.15

umol/l

12.45

443

1668

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

782

3724

2.00

69.58

1.2

1.3

0.22

0.20

nmol/l

0.10

498

2950

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1753

10568

1.59

69.17

1.6

1.8

1.34

1.17

g/l

98.95

1688

10130

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

495

1977

2.37

68.59

20.8

20.5

2923.28

2672.50

nmol/l

0.05

481

1900

(3017817) Protein [Mass] in Urine collected for unspecified duration

562

2373

2.25

68.42

2.6

1477.19

1066.59

3.16

557

2348

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

475

1868

2.41

68.13

15.4

3539.21

1355.75

nmol/l

0.37

461

1812

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4436

32044

1.34

66.91

7.8

6.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1712

10382

1.58

65.81

1.9

2.4

2.95

2.86

g/l

3.67

1576

9525

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1008

5313

1.81

65.76

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1007

5312

1.81

65.52

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1520

8983

1.62

65.10

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

851

4274

1.89

64.75

6.7

5.5

356.98

370.94

umol/l

2.04

760

3752

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1290

7346

1.68

63.95

1.5

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1566

9385

1.60

63.27

1.8

2.3

10.06

10.10

g/l

0.15

1415

8444

(3052851) Hemolysis interference index of Serum or Plasma

1370

7969

1.64

62.53

3.2

3.1

2.15

2.23

index

0.13

705

4032

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1444

8512

1.62

62.47

2.2

2.1

11.89

11.12

mg/l

2.32

1354

8023

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3532

24944

1.37

61.35

3.0

2.2

8.97

12.94

nmol/l

172.98

3153

22798

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1567

9490

1.58

60.51

2.0

2.5

0.47

0.73

g/l

2.67

1384

8240

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1268

7339

1.65

59.00

2.2

1.9

153.71

199.11

pmol/l

39.35

1183

7010

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

384

1465

2.48

58.90

2.5

2.2

152.70

137.63

umol/l

0.34

200

713

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

555

2479

2.12

58.78

1.1

293.34

405.53

mg/l

0.48

486

2295

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

313

1090

2.72

57.80

2.0

2.1

178.96

86.58

ug/min

0.57

236

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3373

24023

1.35

55.17

3.1

2.6

65.58

70.39

ml/min/173m2

7.80

1669

9751

(3023420) DNA double strand Ab [Units/volume] in Serum

2158

14306

1.45

53.88

1.7

1.9

5.95

7.58

iu/ml

2.29

484

3369

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

856

4570

1.78

53.50

1.6

1.3

7.40

6.90

mmol/l

5.74

761

4087

(3022806) Fractional oxyhemoglobin in Capillary blood

656

3223

1.93

53.38

2.3

1.7

89.35

90.29

3.84

644

3173

(3023511) Choriogonadotropin [Units/volume] in Urine

1432

8766

1.56

52.68

1.4

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

655

3253

1.91

51.62

2.2

2.0

24.57

24.70

mg/l

0.02

281

1182

(3010838) Calcium [Moles/time] in 24 hour Urine

988

5569

1.69

50.88

2.1

1.9

5.12

5.20

mmol/24h

0.28

897

5041

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1276

7670

1.59

50.81

1.5

1.7

—

(21494755) Public health laboratory ask at order entry panel

2966

36583

0.74

50.15

1.4

1.3

—

(40768441) Liver Pathology biopsy report

482

2178

2.10

49.60

1.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

537

2529

2.01

49.40

1.6

30.36

33.40

1.04

325

1566

(3012565) Volume of 24 hour Urine

350

1389

2.38

49.34

2.3

2.2

1930.56

2024.12

0.90

317

1270

(40761536) Microorganisms panel - Urine sediment

3492

25402

1.32

49.17

4.8

3.7

—

(3036489) Thrombin time

1882

12404

1.45

48.36

1.9

2.2

20.70

20.85

0.47

1619

10869

(3044242) Glucose [Moles/volume] in Arterial blood

341

1350

2.39

48.35

2.1

2.0

8.71

7.96

mmol/l

2.89

341

1350

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1591

10151

1.50

48.23

2.4

2.7

3.98

3.54

g/l

25.59

1522

9728

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1332

8182

1.55

48.23

1.9

2.3

0.00

0.03

g/l

7.24

1219

7372

(3006571) Granulocytes/Leukocytes in Synovial fluid

660

3360

1.86

48.21

1.6

57.65

54.88

0.91

404

2137

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

879

4879

1.71

47.92

1.5

1.7

—

(3020491) Glucose [Moles/volume] in Blood

467

2120

2.09

47.49

2.0

1.6

7.14

6.46

mmol/l

4.08

319

1615

(3004451) EKG impression Narrative

342

1368

2.36

47.39

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2440

16920

1.38

46.93

1.1

1.44

10.12

u/ml

2.25

202

(36660697) Celiac disease serology panel - Serum

3736

27697

1.30

45.61

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

828

4586

1.71

45.51

2.9

3.5

1.30

1.58

1.64

731

4152

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1198

7289

1.56

45.24

1.9

2.4

0.00

g/l

-0.00

1126

6841

(3019230) Fractional oxyhemoglobin in Venous blood

1047

6175

1.61

45.14

4.2

3.2

65.47

62.36

4.89

1042

6155

(3016650) Hepatitis A virus Ab [Presence] in Serum

965

5580

1.64

45.05

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1020

6007

1.61

44.24

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

684

3617

1.79

44.20

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1265

7832

1.54

44.18

1.9

2.4

0.00

g/l

1.51

1132

6852

(3000034) Microalbumin [Mass/volume] in Urine

474

2223

2.02

44.16

3.6

2.8

66.48

49.23

mg/l

0.77

358

1557

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1979

13389

1.41

43.96

1.3

0.44

0.95

u/ml

2.68

176

1027

(3005988) Vibrio sp identified in Specimen by Organism specific culture

685

3634

1.79

43.79

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

684

3630

1.79

43.68

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

353

1489

2.24

43.27

1.7

1.8

1.91

1.97

umol/l

0.74

331

1350

(3022621) pH of Urine by Test strip

3410

25152

1.30

43.11

2.9

2.4

6.02

6.11

6.38

2253

16205

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

2567

31676

0.74

43.04

1.6

3.43

3.47

mmol/l

0.82

1774

21247

(3002256) Pathology report gross observation

5330

41578

1.24

42.33

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

705

3820

1.75

41.93

1.4

—

(3037756) Immunofixation for Serum or Plasma

914

5314

1.63

41.77

1.4

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

716

3902

1.74

41.73

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1610

10624

1.45

41.02

2.0

2.3

94.95

93.94

0.99

1541

10221

(3036603) Volume of Urine

470

2258

1.97

40.95

1.6

1.7

2093.41

2028.00

0.62

458

2217

(3051387) C reactive protein [Mass/volume] in Capillary blood

967

5737

1.60

40.69

4.6

3.1

23.88

26.46

mg/l

1.49

709

3838

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5682

44842

1.23

40.22

2.2

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1110

6830

1.55

39.87

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

696

3821

1.73

39.54

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

274

1081

2.40

39.26

2.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

766

4329

1.68

39.11

1.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

310

1293

2.27

39.10

1.5

1.4

430.47

707.10

mu/l

2.17

294

1237

(3012898) Urea [Moles/volume] in Urine

114

273

3.94

38.89

1.8

1.5

185.58

167.92

mmol/l

0.80

109

238

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

939

5606

1.59

38.50

1.5

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1496

9871

1.44

38.11

2.3

2.6

196.49

184.32

5.89

1429

9381

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

312

1321

2.23

37.98

1.5

1.4

72.61

73.18

0.28

296

1265

(3048929) Epstein Barr virus Ab [Presence] in Serum

1753

11919

1.40

37.75

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6136

49092

1.21

37.57

2.3

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

766

4380

1.66

37.41

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3617

41909

0.79

36.81

1.9

3.81

3.41

ratio

53.64

2768

31544

(3047181) Lactate [Moles/volume] in Blood

1301

8415

1.47

36.78

7.3

5.4

1.39

1.28

mmol/l

4.53

1174

7458

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

820

4799

1.62

36.53

1.3

1.5

17.72

13.52

u/ml

0.28

110

(3024980) IgG subclass 4 [Mass/volume] in Serum

920

5544

1.58

36.26

1.4

1.6

0.71

0.75

g/l

0.64

724

4342

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

943

5717

1.57

36.20

1.4

—

(3001556) Androgen free Index in Serum or Plasma

122

324

3.55

35.93

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1316

8577

1.46

35.77

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

370

1717

2.04

35.61

2.0

1.9

104.19

99.09

ng/l

0.34

370

1712

(3014765) Yersinia sp identified in Stool by Organism specific culture

1322

8632

1.46

35.59

1.2

—

(4034850) Laboratory test

1357

8907

1.45

35.54

11.1

9.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

877

5254

1.58

35.45

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1757

12079

1.39

35.41

1.4

—

(3044927) Protein electrophoresis panel - Urine

459

2300

1.89

35.36

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1321

8649

1.45

35.06

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

919

5580

1.56

35.05

1.1

—

(3008898) HLA-B27 [Presence]

1850

12891

1.37

34.30

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

654

3676

1.69

34.14

1.6

—

(40768443) Skin Pathology biopsy report

1972

13896

1.35

34.03

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

166

550

2.85

33.92

1.2

—

(4195642) Thrombophilia screening test

839

5027

1.58

33.91

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

715

4133

1.64

33.51

2.9

2.7

638.59

673.51

u/ml

0.03

708

4083

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

172

591

2.75

32.85

1.2

318.46

337.17

pmol/l

0.18

122

450

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

573

3140

1.73

32.85

1.2

57.88

64.32

u/l

1.70

510

2757

(3002079) Sodium [Moles/time] in 24 hour Urine

326

1491

2.07

32.68

1.3

178.99

154.67

mmol/24h

4.99

326

1491

(3010144) Erythrocytes [#/volume] in Synovial fluid

494

2599

1.80

32.60

1.5

1.4

106128.25

108597.83

e6/l

0.03

350

1710

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

28889

261947

1.17

32.30

26.7

17.3

13.93

13.47

307.65

28690

258667

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

884

5447

1.54

31.60

1.3

4.34

3.98

u/ml

0.32

393

2567

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

903

5614

1.53

30.99

1.3

3.80

3.58

u/ml

0.12

317

2163

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

433

2239

1.83

30.29

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

2127

15418

1.32

30.19

2.0

2.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1358

9191

1.41

30.01

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

447

2344

1.80

29.87

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

447

2344

1.80

29.87

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

447

2344

1.80

29.87

1.4

1.7

—

(3014271) Vancomycin [Susceptibility]

235

980

2.26

29.80

3.1

2.8

—

(3007461) Platelets [#/volume] in Blood

35958

333845

1.42

29.70

34.5

21.7

263.98

255.60

e9/l

110.55

35559

327856

(3000764) Benzodiazepines [Presence] in Urine

2261

16566

1.30

29.65

2.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

475

2544

1.77

29.56

1.2

141.38

193.99

titre

0.81

404

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

617

3551

1.65

29.47

1.6

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

472

2539

1.76

28.95

1.2

210.91

173.04

titre

0.13

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

824

5103

1.53

28.81

1.1

124.61

116.91

9.06

748

4645

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

204

816

2.36

28.51

1.3

1.2

51.46

71.09

ug/l

9.16

204

816

(3024731) MCV [Entitic mean volume] in Red Blood Cells

35960

333974

1.41

28.50

34.3

21.6

90.19

90.82

123.62

35762

331174

(3035941) MCH [Entitic mass]

35959

333967

1.41

28.46

34.3

21.6

29.81

30.29

307.65

35760

331174

(3028300) Cannabinoids [Presence] in Urine

2264

16692

1.29

28.29

2.0

2.1

—

(3027008) Opiates [Presence] in Urine

2258

16643

1.29

28.28

2.0

—

(3026361) Erythrocytes [#/volume] in Blood

35960

334003

1.40

28.18

34.4

21.6

4.57

4.50

e12/l

112.16

35482

327075

(3004716) Salmonella sp identified in Stool by Organism specific culture

2308

17073

1.29

28.11

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

35958

333989

1.40

28.10

35.3

22.1

40.87

40.91

0.10

35758

331065

(3010813) Leukocytes [#/volume] in Blood

35963

334049

1.40

28.04

34.5

21.7

7.42

6.64

e9/l

307.65

35475

327088

(3000963) Hemoglobin [Mass/volume] in Blood

35964

334078

1.40

27.84

34.7

21.8

134.97

135.56

g/l

12.02

35776

331340

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

152

535

2.68

27.80

1.4

1.7

0.84

1.22

nmol/l

1.24

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1547

10835

1.36

27.73

1.6

1.60

6.10

iu/ml

0.95

281

1875

(43055514) Macroprolactin [Presence] in Serum or Plasma

231

987

2.21

27.67

1.5

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

246

1086

2.14

27.16

2.0

2.6

0.68

1.21

ug/l

6.60

225

1042

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

368

1875

1.86

27.05

1.4

1.5

21.22

24.90

u/ml

0.66

325

(3027135) IgG subclass 1 [Mass/volume] in Serum

594

3466

1.62

26.90

1.4

6.38

6.77

g/l

2.20

431

2532

(3028192) IgG subclass 2 [Mass/volume] in Serum

593

3460

1.62

26.86

1.4

2.82

2.98

g/l

1.44

434

2527

(3024139) IgG subclass 3 [Mass/volume] in Serum

592

3461

1.62

26.61

1.4

0.39

0.41

g/l

0.22

433

2529

(4062490) Immunoglobulin typing, IgG

584

3404

1.62

26.57

1.4

—

(3034891) Synovial lining cells/cells in Synovial fluid

285

1345

2.00

26.34

1.5

5.06

3.70

0.62

298

(3000012) Reticulocyte production index

606

3581

1.60

26.07

2.2

1.05

0.89

5.48

423

2406

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

355

1816

1.85

25.80

1.6

1.3

5.68

5.51

mmol/l

2.01

333

1727

(37021550) Renin [Units/volume] in Plasma --upright

147

532

2.61

25.49

1.3

97.53

77.45

mu/l

0.40

108

406

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1332

9244

1.37

25.31

2.4

2.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

335

1693

1.87

25.30

1.3

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2404

18104

1.27

25.30

2.8

3.4

40.91

50.98

u/ml

1.47

2315

17535

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

413

2227

1.75

25.20

1.8

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1073

7191

1.42

25.12

1.5

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

393

2093

1.77

25.03

1.5

—

(3027944) Amphetamines [Presence] in Urine

2202

16445

1.28

24.81

2.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

330

1671

1.87

24.79

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

487

2760

1.67

24.78

2.7

3.6

—

(3006270) Folate [Moles/volume] in Blood

392

2096

1.77

24.64

1.2

1.1

385.23

377.39

nmol/l

0.30

309

1863

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1705

12328

1.32

24.60

2.0

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

472

2659

1.68

24.58

1.2

111.45

112.74

pmol/l

0.20

472

2659

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1399

9836

1.35

24.46

1.3

7.74

5.64

u/ml

0.38

112

929

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1397

9824

1.35

24.40

1.3

5.26

8.95

u/ml

2.44

164

1424

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1219

8395

1.38

24.31

1.3

15.31

16.29

u/ml

0.04

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1062

7154

1.41

24.15

1.5

1.4

14.79

22.17

u/ml

1.68

132

(40757494) Bilirubin.total [Moles/volume] in Blood

269

1284

1.98

24.12

2.2

2.1

22.84

27.18

umol/l

0.24

116

(3018851) Theophylline [Moles/volume] in Serum or Plasma

181

3.80

23.90

1.8

1.9

45.28

47.24

umol/l

0.23

181

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1482

10556

1.33

23.76

1.3

30.10

40.00

u/ml

0.54

582

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1187

8173

1.38

23.70

1.3

4.27

4.93

u/ml

0.14

546

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1380

9731

1.35

23.67

2.0

19.15

16.70

iu/l

0.07

559

4098

(3017354) Segmented neutrophils/Leukocytes in Blood

515

3005

1.62

23.40

2.8

3.5

59.29

56.77

2.02

437

2616

(3019832) Treponema pallidum Ab [Presence] in Serum

5493

45167

1.17

23.33

1.9

1.8

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

235

1085

2.04

23.15

1.3

1.4

13.25

14.64

pmol/l

3.54

196

920

(3008116) Ketones [Moles/volume] in Urine by Test strip

162

644

2.37

23.08

1.5

0.29

mmol/l

0.00

115

(44790048) Parainfluenza type 2 nucleic acid detection

630

3866

1.54

23.07

1.5

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

629

3865

1.54

22.90

1.5

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

912

6038

1.43

22.88

2.1

2.2

5.99

6.28

umol/l

0.25

662

4427

(44790049) Parainfluenza type 3 nucleic acid detection

628

3865

1.54

22.70

1.5

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

318

1640

1.83

22.59

1.2

1.3

72.11

76.05

titre

0.06

114

(44790047) Parainfluenza type 1 nucleic acid detection

628

3871

1.54

22.54

1.5

1.6

—

(3023419) Bacteria identified in Sputum by Culture

583

3535

1.56

22.53

2.4

2.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2081

15633

1.27

22.31

1.6

1.4

—

(3039000) Anion gap in Blood by calculation

858

5644

1.44

22.30

8.8

6.5

11.42

11.23

mmol/l

0.94

789

5090

(3018572) Chloride [Moles/volume] in Blood

858

5645

1.44

22.28

8.8

6.5

105.12

105.22

mmol/l

0.29

789

5092

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

252

1210

1.97

22.27

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

252

1211

1.96

22.22

1.3

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

624

3859

1.53

22.07

1.1

99.64

95.73

2.98

593

3623

(21494890) Protein electrophoresis panel - 24 hour Urine

463

2674

1.64

21.96

1.5

2.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

322

1683

1.81

21.92

1.2

1.3

792.86

441.52

titre

0.51

(3006922) Hepatitis E virus Ab [Presence] in Serum

461

2662

1.64

21.88

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

286

1446

1.87

21.66

1.1

6.76

10.45

u/ml

1.10

261

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

451

2604

1.64

21.42

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1071

7378

1.38

21.35

1.2

1.3

47.45

44.94

u/ml

0.06

117

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1081

7467

1.37

21.20

1.2

1.3

3.96

3.68

mmol/l

12.70

1016

7083

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

206

937

2.07

21.18

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

977

6640

1.39

21.14

1.5

151.84

149.02

au/ml

0.28

235

1913

(43055442) Apixaban [Mass/volume] in Serum or Plasma

103

344

2.82

20.95

1.6

112.91

112.92

ug/l

0.00

292

(3051101) Glucose [Moles/volume] in Cord blood

105

355

2.79

20.88

6.3

5.3

8.55

8.38

mmol/l

0.19

105

355

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2418

18629

1.24

20.73

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

303

1585

1.81

20.60

1.4

1.2

273.74

330.44

u/l

0.55

286

1476

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

324

1732

1.77

20.48

1.3

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

114

407

2.64

20.42

15.0

9.6

5.56

5.21

mmol/l

0.67

114

407

(3026692) Albumin [Mass/volume] in Peritoneal fluid

166

705

2.22

20.34

1.5

1.4

13.27

13.50

g/l

0.12

135

520

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

274

1404

1.84

19.94

1.7

1.8

28.67

28.94

umol/l

0.16

263

1305

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

424

2460

1.63

19.80

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1120

7872

1.35

19.67

1.4

135.20

122.15

pmol/l

0.35

1085

7685

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

427

2490

1.62

19.54

3.2

2.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1231

8789

1.33

19.45

1.5

42.73

62.39

ug/l

86.43

1231

8789

(3035320) C reactive protein [Mass/volume] in Body fluid

412

2387

1.63

19.36

3.6

2.5

22.04

28.44

mg/l

4.12

324

1687

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

726

4763

1.44

19.21

1.2

16.94

17.12

u/ml

0.01

217

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

123

470

2.47

19.20

3.5

2.1

7.70

7.38

mmol/l

0.34

286

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1000

6933

1.37

19.20

1.3

271.23

257.47

u/ml

0.82

598

4508

(3002331) Protein [Mass/volume] in Peritoneal fluid

148

615

2.27

19.14

1.4

26.48

57.43

g/l

0.54

110

468

(3035947) Staphylolysin Ab [Units/volume] in Serum

275

1432

1.81

19.03

1.2

1.1

3.57

3.65

iu/ml

0.06

102

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

392

2254

1.64

19.00

1.1

—

0.20

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1096

13635

0.75

18.99

1.1

0.68

0.61

ratio

1.91

126

1614

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

544

3384

1.52

18.81

1.8

1.6

8.52

7.51

mmol/l

19.89

511

3266

(3000093) Morphology [Interpretation] in Blood Narrative

447

2665

1.59

18.69

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

359

2031

1.67

18.55

1.4

1.5

6.73

8.42

ug/l

1.87

329

1850

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

186

858

2.04

18.49

5.0

2.9

5.35

4.84

kpa

5.12

186

858

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

186

859

2.04

18.43

5.0

2.9

9.72

10.64

kpa

4.95

186

859

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

185

854

2.04

18.36

2.3

1.8

6592.53

12782.58

e6/l

0.99

424

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1237

8914

1.32

18.32

1.2

1.1

—

(3024263) Appearance of Synovial fluid

260

1347

1.82

18.32

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2196

16969

1.23

18.28

1.1

207.23

182.93

titre

0.12

469

(3004616) Nuclear Ab [Presence] in Serum

646

4186

1.46

18.27

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3011

24003

1.20

18.21

1.6

631.07

1056.52

mu/l

95.14

2463

20366

(4024509) Urine culture

1800

13616

1.26

18.19

2.1

1.8

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

570

3608

1.49

18.15

1.2

1.1

1.10

2.15

iu/ml

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

5.86

18.14

4.8

5.8

0.23

0.24

mmol/l

0.09

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

105

383

2.58

18.08

2.0

2.1

—

(3042631) Mycobacterium sp identified in Specimen

543

3406

1.51

18.07

2.3

2.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

326

1812

1.70

18.01

1.2

1.3

79.76

92.46

u/l

2.06

283

1549

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

153

663

2.18

17.91

1.3

1.2

19.53

10.17

pmol/l

2.34

238

(3023487) Leukocytes [#/volume] in Peritoneal fluid

207

1004

1.95

17.88

2.5

1.9

2946.34

2924.53

e6/l

0.00

137

659

(3032057) Clostridioides difficile [Presence] in Stool

123

487

2.38

17.81

2.0

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

443

2670

1.57

17.70

1.2

1.3

0.95

2.01

u/ml

2.94

249

1527

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1175

8459

1.32

17.54

1.3

528.55

520.08

mg/l

0.11

1126

8115

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

303

1668

1.72

17.37

1.1

1.2

21.53

23.05

u/l

0.23

273

1491

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

317

1774

1.69

17.11

1.2

1.3

21.42

24.91

u/l

0.79

267

1498

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

314

1753

1.69

17.10

1.5

1.6

6.42

7.18

u/l

0.51

244

1394

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

454

2781

1.54

16.91

1.5

1.8

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

320

2.68

16.89

1.1

1.0

0.99

1.23

mom

2.85

320

(3020191) Ethanol [Moles/volume] in Serum or Plasma

445

2720

1.55

16.74

1.6

1.5

1.21

1.32

promille

0.85

352

2155

(3013166) Neutrophils/Leukocytes in Synovial fluid

163

746

2.06

16.61

1.5

1.4

54.34

52.09

0.31

141

639

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

302

1683

1.69

16.58

1.1

1.2

80.25

82.29

u/l

0.24

275

1503

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

538

3433

1.48

16.51

1.2

68.71

42.66

u/ml

0.79

179

(3006576) Bicarbonate [Moles/volume] in Blood

177

840

1.99

16.33

6.8

6.3

25.71

24.92

mmol/l

1.38

161

771

(4268621) Lupus anticoagulant assay

602

3939

1.45

16.24

2.4

2.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

366

2.50

15.65

2.9

2.3

1.17

1.19

mmol/l

0.03

253

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

482

3044

1.50

15.60

1.5

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

374

2245

1.57

15.30

1.4

1.7

208.23

833.83

pmol/l

1.12

288

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

363

2167

1.58

15.20

1.1

1.06

ratio

0.42

305

1799

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

764

5282

1.37

15.03

2.3

3.1

490.89

7242.33

u/ml

1.81

299

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

108

437

2.33

14.98

2.0

1.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

351

2087

1.59

14.96

2.0

1.8

2.02

2.93

u/field

0.38

200

1172

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

261

1439

1.71

14.96

1.4

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

261

1439

1.71

14.96

1.4

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

261

1439

1.71

14.96

1.4

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1040

7530

1.31

14.95

1.4

1.5

1596.63

2209.76

e6/l

0.29

817

5894

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

220

1159

1.79

14.79

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1025

7432

1.31

14.59

1.3

1.4

71.07

27.18

e6/l

1.26

762

5452

(40762365) Oxygen content in Arterial blood by calculation

374

2.42

14.50

3.3

2.9

14.95

14.82

ml/dl

0.17

349

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

298

1718

1.64

14.44

1.5

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1150

8479

1.28

14.41

1.1

1.64

2.14

u/ml

1.22

655

4428

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

345

2064

1.58

14.35

2.1

99.93

99.02

0.19

321

1924

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

259

1443

1.69

14.31

1.4

1.9

—

(3003181) Sodium [Moles/volume] in Urine

711

4899

1.37

14.31

1.3

1.4

62.37

62.60

mmol/l

0.05

526

3887

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

225

1206

1.76

14.28

1.2

110.35

110.32

0.01

200

1095

(44813793) Dust mix specific IgE antibody measurement

406

2523

1.52

14.25

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

118

510

2.18

14.03

2.5

2.8

69.57

32.47

mg/l

1.19

119

(3002619) Bacteria identified in Specimen by Culture

162

788

1.94

14.01

1.3

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

946

6825

1.31

13.99

5.1

6.2

6374.01

1110.13

iu/ml

0.44

110

1017

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

129

581

2.09

13.82

1.2

14.34

83.14

mg/l

1.96

416

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

235

1289

1.72

13.77

1.2

0.32

0.30

g/l

4.50

192

1024

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6111

63113

0.89

13.77

4.1

4.3

22.62

21.81

2.97

2470

29714

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1087

8006

1.29

13.76

1.3

40.17

44.61

u/ml

0.31

737

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

449

2878

1.47

13.58

1.2

1.3

77.00

67.66

u/ml

0.19

112

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1264

14793

0.80

13.55

1.2

0.88

g/l

0.10

1256

14755

(3051611) Lipemic interference index of Serum or Plasma

432

2749

1.48

13.55

3.6

3.4

16.36

14.28

index

1.32

265

1571

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

181

924

1.85

13.53

1.4

1.2

89.66

134.58

nmol/l

4.71

130

685

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1722

13392

1.22

13.49

1.4

1.3

197.03

227.31

miu/ml

3.09

750

6448

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1511

11594

1.24

13.48

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

129

588

2.07

13.40

3.0

2.5

244.24

236.86

ug/l

0.01

129

588

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

256

1454

1.66

13.20

2.3

2.5

22.87

152.22

ug/l

1.80

245

1390

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

104

441

2.22

12.99

4.8

5.6

60.10

38.29

ug/min

1.85

331

(3027570) Oxalate [Moles/time] in 24 hour Urine

190

2.92

12.99

2.0

1.3

347.78

316.10

umol/24h

0.51

190

(3038026) Centromere Ab [Units/volume] in Serum

391

2470

1.49

12.75

1.2

1.3

45.01

49.82

u/ml

0.14

156

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1645

12821

1.22

12.62

1.4

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

211

1153

1.73

12.59

3.1

3.2

1.14

1.36

0.94

211

1153

(3026389) Candida sp identified in Specimen by Organism specific culture

714

5032

1.34

12.49

1.5

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

278

1636

1.60

12.48

1.6

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1208

9124

1.25

12.45

1.2

3.55

4.05

1.29

142

1438

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

938

6877

1.29

12.35

1.5

0.39

0.42

nmol/l

0.42

750

5354

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

252

1454

1.64

12.26

1.1

100.66

96.15

1.40

186

1164

(40768446) Kidney Pathology biopsy report

229

1293

1.67

12.13

1.6

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

996

7383

1.28

12.03

1.1

3.63

5.23

u/ml

4.13

555

3840

(3008401) Mugwort IgE Ab [Units/volume] in Serum

957

7062

1.28

11.99

1.1

0.64

1.10

u/ml

2.47

433

3063

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

191

1030

1.75

11.97

1.4

2.1

38.75

40.85

g/l

5.77

191

1030

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

103

3.57

11.84

2.1

2.0

288.11

229.99

ug/l

0.96

103

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

105

465

2.13

11.83

7.3

6.8

66.50

69.82

0.58

354

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

369

2345

1.49

11.73

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

264

1562

1.59

11.63

1.6

1.5

—

(4198724) Urine methamphetamine measurement

273

1631

1.58

11.54

2.5

2.4

—

(3044007) Cell count panel - Peritoneal fluid

164

856

1.81

11.50

2.6

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

364

2317

1.48

11.49

1.2

—

(3051651) Icteric interference index of Serum or Plasma

270

1613

1.58

11.42

3.6

3.7

0.75

0.87

index

1.56

265

1569

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

198

1094

1.71

11.40

2.9

2.8

0.61

mmol/l

0.04

198

1094

(3043410) Blood group antigens tested for on Red Blood Cells

149

759

1.85

11.31

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

805

5863

1.30

11.19

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

161

848

1.79

10.98

1.7

1.6

10.76

8.96

ug/l

4.42

161

848

(40768800) Prostate Pathology biopsy report

365

4948

0.69

10.96

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

224

1300

1.63

10.72

5.4

4.7

1784.64

2553.74

mg/l

0.24

156

964

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

309

1931

1.51

10.71

1.1

2.28

6.39

nmol/l

2.00

348

(3027035) Albumin [Mass/time] in 24 hour Urine

248

2.47

10.41

1.4

1.3

669.01

231.42

mg/24h

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3720

31380

1.13

10.38

2.1

—

(3042733) HLA Ab [Presence] in Serum

197

1117

1.66

10.35

5.1

5.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4604

47619

0.90

10.35

3.0

3.1

0.68

0.75

ug/l

3.96

2982

29771

(3036670) Protein [Mass/volume] in Synovial fluid

148

779

1.79

10.16

1.3

36.81

40.59

g/l

2.32

401

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

218

2.55

10.11

3.0

2.2

65.78

58.25

0.80

132

(3014148) Varicella zoster virus Ab [Titer] in Serum

712

5180

1.30

10.04

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

230

2.50

10.03

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

386

2556

1.43

9.98

3.3

3.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2839

23598

1.14

9.97

2.4

21.68

20.77

au/ml

0.22

253

2869

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

312

2.26

9.93

1.1

0.09

0.04

u/ml

0.55

312

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2641

21859

1.15

9.88

1.3

38.82

50.51

au/ml

1.93

120

1351

(3012494) Peanut IgE Ab [Units/volume] in Serum

173

964

1.69

9.74

1.1

3.30

6.56

u/ml

0.42

563

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

449

3066

1.38

9.73

1.4

1.5

—

(3008295) Osmolality of Serum or Plasma

453

3107

1.38

9.56

1.5

283.44

279.24

mosm/kgh2o

3.39

333

2398

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

441

2.03

9.55

1.1

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

144

2.88

9.52

1.7

0.61

0.70

0.16

108

(3001729) Color of Synovial fluid

176

2.68

9.45

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

781

5804

1.27

9.35

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

407

2.06

9.33

1.4

1.3

5.91

5.70

mmol/l

1.07

407

(4094501) Cardiovascular stress test using bicycle ergometer

1092

8446

1.22

9.15

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3085

25951

1.13

9.00

2.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

392

2654

1.39

8.98

1.1

7.35

8.25

iu/ml

0.38

102

743

(4281824) Cell count and differential, peritoneal fluid

483

3393

1.34

8.79

1.2

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

105

521

1.90

8.76

1.1

1.0

0.24

0.29

u/ml

0.10

319

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

450

1.97

8.72

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

235

1455

1.52

8.62

1.7

2.87

2.41

u/field

0.24

164

1052

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

180

1049

1.62

8.59

1.4

2.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

182

1065

1.61

8.54

1.5

2.2

—

(3023410) Appearance of Cerebral spinal fluid

482

3403

1.34

8.50

1.4

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

272

1743

1.47

8.45

1.1

—

(3006462) Nitrate [Presence] in Urine

220

1350

1.54

8.42

3.5

2.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

179

1049

1.61

8.36

1.5

2.2

—

(4211845) Urine protein measurement

238

1488

1.51

8.36

3.3

2.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

196

1175

1.57

8.32

3.5

4.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

246

1551

1.50

8.30

1.3

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

598

4371

1.29

8.23

1.3

38.85

55.96

u/ml

0.88

265

(3018133) Calcium [Moles/volume] in Urine

115

603

1.80

8.10

1.8

2.85

2.68

mmol/l

0.36

104

559

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

186

2.48

8.02

1.2

125.27

99.03

ug/l

0.63

117

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

175

2.53

8.01

3.0

2.2

16.74

17.20

0.03

(4015189) Microbial culture of sputum

117

619

1.78

8.01

2.5

2.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

109

568

1.81

7.85

1.1

0.87

0.77

umol/24h

0.17

289

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.07

7.82

1.7

1.5

233.33

220.59

nmol/l

0.04

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

245

1567

1.47

7.74

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

415

2909

1.35

7.73

1.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

1629

0.56

7.65

1.6

1.5

0.53

0.51

e9/l

0.22

1629

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

316

2125

1.40

7.62

2.8

3.5

103.64

148.38

nmol/l

2.04

309

2087

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

281

1851

1.43

7.61

1.5

1.4

13.51

12.46

u/l

1.49

275

1797

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

153

2.58

7.50

1.3

1.6

523.26

512.11

nmol/l

0.04

153

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1178

9362

1.19

7.49

1.1

3.89

5.49

eliau/ml

1.01

134

1346

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

148

2.61

7.46

1.0

0.27

0.09

u/ml

0.66

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

250

1618

1.46

7.45

1.2

23.16

9.29

u/ml

0.29

193

(3026470) Cobalt [Mass/volume] in Blood

216

1365

1.49

7.27

2.2

2.3

4.76

3.26

ug/l

1.46

196

1272

(3016038) Potassium [Moles/volume] in Urine

275

1822

1.42

7.24

1.1

1.2

32.07

33.89

mmol/l

0.74

235

1605

(3003434) Protein [Mass/volume] in Pleural fluid

458

3292

1.31

7.21

1.5

1.4

33.53

33.73

g/l

0.13

423

3004

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

415

5138

0.76

7.20

3.2

3.9

23.50

37.90

u/ml

4.25

395

4962

(3043238) Trisomy 21 risk [Likelihood] in Fetus

977

10974

0.83

7.13

1.6

—

(3017704) Immunofixation for Urine

216

1371

1.49

7.13

1.2

1.8

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

245

1598

1.45

7.04

2.0

200.13

197.00

u/l

0.35

245

1585

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

208

1315

1.49

7.01

2.1

6.88

9.45

mg/l

11.29

176

1086

(3024932) HLA-DR beta [Type]

167

1007

1.56

7.00

1.1

—

(40762814) Titanium [Mass/volume] in Blood

367

1.95

6.97

2.4

2.7

3.56

3.72

ug/l

0.09

143

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

659

4988

1.25

6.88

1.1

2.66

2.83

0.21

922

(3042517) Benzodiazepines panel - Urine

457

1.83

6.79

2.8

2.9

—

(3005033) Fetal Nuchal fold Thickness US

942

10559

0.84

6.74

1.5

1.27

1.26

0.32

597

7793

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

263

2.11

6.74

1.0

1.2

39.01

45.90

mg/l

1.74

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

265

1775

1.41

6.61

1.7

2.0

150.81

142.11

1.11

253

1684

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

190

1198

1.49

6.52

1.1

97.16

90.49

2.39

555

(3025577) Chromium [Mass/volume] in Blood

208

1336

1.47

6.51

2.2

2.3

2.46

2.31

ug/l

0.20

164

1122

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

452

3294

1.29

6.48

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

896

7050

1.20

6.43

1.1

1.52

1.85

u/ml

0.64

496

3475

(3024471) HLA-A [Type]

168

1036

1.53

6.42

1.0

—

(44806071) Cardiolipin IgM antibody measurement

473

1.79

6.40

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

799

6222

1.21

6.39

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

281

1913

1.38

6.39

1.6

1.4

6.12

6.13

u/l

0.01

249

1632

(3047352) Trisomy 18 risk [Likelihood] in Fetus

967

10757

0.84

6.37

1.5

—

(40762887) Creatinine [Moles/volume] in Blood

203

2.23

6.27

1.5

1.4

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

259

2.07

6.22

1.0

0.05

1.38

u/ml

1.26

241

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

366

2608

1.32

6.21

1.2

1.3

2.17

2.04

mmol/l

0.81

342

2437

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

363

2584

1.32

6.20

1.2

87.27

81.03

1.90

182

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

186

1183

1.48

6.15

2.3

2.7

163.80

145.48

au/ml

0.23

193

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

224

2.14

6.08

1.4

1.3

0.98

1.59

ml/s/173m2

0.81

150

(3042301) Urate [Moles/volume] in Synovial fluid

3.76

6.01

1.0

452.00

374.50

umol/l

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

190

1227

1.46

5.84

1.1

1.2

119.76

109.26

3.12

175

1114

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

191

1235

1.46

5.84

2.8

2.5

146.52

151.24

nmol/l

0.28

171

1102

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

318

2242

1.34

5.83

1.4

1.3

404.26

507.60

u/l

1.13

296

2138

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

119

694

1.62

5.83

1.3

39.01

40.97

0.19

473

(3051339) Copper [Moles/volume] in Blood

156

2.35

5.81

1.3

17.79

16.20

umol/l

1.11

134

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

665

5139

1.22

5.79

1.2

1.51

1.07

0.40

241

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

192

1246

1.45

5.76

1.1

1.0

6.05

10.44

u/ml

3.83

110

816

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

207

1363

1.43

5.75

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

404

2959

1.29

5.64

1.5

2987.32

3730.68

e6/l

0.29

292

2051

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

460

3427

1.27

5.60

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

3.44

5.59

1.5

1.4

454.47

389.92

mg/24h

0.28

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1294

13922

0.87

5.58

1.6

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

201

1337

1.42

5.32

3.0

3.5

7.61

8.74

mg/l

1.42

158

1077

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

558

1.65

5.32

1.2

1.5

0.20

0.28

nmol/l

1.30

398

(3047189) Immunofixation for 24 hour Urine

182

1191

1.44

5.27

1.5

1.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

407

3015

1.27

5.23

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

652

5093

1.21

5.15

1.9

2.1

7.50

8.94

titre

0.10

120

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

317

2279

1.31

5.14

1.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

136

2.35

5.10

1.0

0.14

0.06

u/ml

0.36

(3016273) Islet cell 512 Ab [Units/volume] in Serum

209

2.07

5.10

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

114

682

1.57

5.08

1.4

1.3

3.66

3.56

mmol/l

0.12

107

628

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

459

5357

0.80

5.07

3.3

2.5

13.49

13.13

9.93

454

5292

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

164

1061

1.46

5.06

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

401

2980

1.27

5.04

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

179

1179

1.43

5.03

1.1

101.13

91.11

2.55

553

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

400

2975

1.27

5.00

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

364

2676

1.28

4.99

1.3

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

117

709

1.55

4.95

1.2

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

448

3382

1.25

4.93

3.2

3.5

4.95

9.01

nmol/l

1.02

416

3281

(21491868) Cryoglobulin [Mass/volume] in Serum

175

1157

1.43

4.83

1.2

0.13

0.54

g/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.78

4.81

1.4

1.2

41.62

31.73

mg/24h

1.14

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

305

2204

1.30

4.79

1.8

1.7

—

(3018333) Ribosomal P Ab [Presence] in Serum

377

2801

1.27

4.77

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

202

2.05

4.77

1.5

1.3

23.69

21.39

mmol/l

1.91

151

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

386

2878

1.26

4.75

1.2

—

(3028433) Virus identified in Specimen by Culture

147

944

1.47

4.75

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

562

1.61

4.72

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

561

4361

1.21

4.70

2.4

2.5

27.03

27.00

iu/ml

0.00

384

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

410

3085

1.25

4.67

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

324

2369

1.29

4.67

1.3

1.4

13.06

11.91

umol/l

2.08

304

2245

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.66

4.64

2.0

1.6

122.50

292.84

nmol/l

1.92

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

117

721

1.53

4.62

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

108

654

1.56

4.61

1.3

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

125

2.33

4.60

1.1

1.0

0.04

0.11

u/ml

0.57

125

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

149

2.21

4.59

1.1

1.2

—

303.33

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

100

596

1.58

4.58

1.3

1.20

1.18

mmol/l

1.73

100

596

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.72

4.47

12.4

8.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

180

2333

0.72

4.46

1.0

—

(44806420) Estimation of glomerular filtration rate

520

4037

1.21

4.44

2.7

2.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

198

1359

1.37

4.44

30.9

30.3

115.31

117.89

ug/l

0.19

163

1111

(3026051) Granulocytes/Leukocytes in Pleural fluid

499

1.62

4.41

1.5

1.4

25.24

23.87

0.17

416

(3001686) Cold agglutinin [Titer] in Serum or Plasma

499

1.62

4.41

1.2

1.4

21.71

346.61

titre

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

383

2883

1.25

4.38

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

116

725

1.51

4.32

7.5

8.8

5.90

5.96

kpa

0.32

100

659

(3028308) Erythrocytes [#/volume] in Pleural fluid

353

2638

1.26

4.31

1.6

1.4

72374.57

50127.39

e6/l

0.72

199

1472

(3000285) Sodium [Moles/volume] in Blood

475

1.63

4.25

1.3

1.2

138.52

138.43

mmol/l

0.08

395

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

447

1.64

4.22

1.6

1.7

436927.65

181010.13

nmol/l

0.48

379

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

394

2990

1.24

4.21

1.1

1.2

43.91

41.98

mg/l

0.32

344

2520

(37208534) Antinuclear antibody arbitrary concentration in serum

172

1165

1.39

4.20

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

219

1544

1.34

4.16

41.3

42.7

7.27

7.33

ug/l

0.19

197

1401

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

382

2896

1.24

4.13

1.1

244.18

259.78

mg/l

0.77

338

2578

(3035880) pH of Pleural fluid

178

1217

1.38

4.12

1.3

7.39

7.40

0.53

129

831

(3012441) Differential panel - Pleural fluid

336

2517

1.26

4.05

1.5

—

1.00

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

362

2737

1.25

4.02

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

119

761

1.47

4.00

1.5

1.6

0.42

0.39

ug/l

0.45

573

(3027231) Wheat IgE Ab [Units/volume] in Serum

117

748

1.47

3.94

1.1

1.15

3.80

u/ml

1.06

643

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.38

3.90

1.0

1.1

1329.50

4272.65

ng/l

2.12

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

162

1102

1.38

3.89

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

2.65

3.89

1.2

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

186

1.97

3.88

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

733

5947

1.16

3.84

1.1

5.04

4.69

u/ml

0.14

338

2624

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

243

1763

1.30

3.81

1.4

1.3

12.82

15.31

u/l

1.15

224

1635

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

318

1.72

3.74

1.0

1.06

0.81

u/ml

0.09

220

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

706

5726

1.16

3.73

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

340

1.69

3.71

1.2

1.77

1.85

iu/ml

0.13

182

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.81

3.67

1.9

2.4

2.38

3.07

mu/l

0.23

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

112

721

1.46

3.67

1.5

1.9

32.49

35.44

u/l

0.08

100

649

(3014133) Dog dander IgE Ab [Units/volume] in Serum

767

6272

1.15

3.64

1.1

4.73

3.99

u/ml

0.41

406

3062

(1175426) CD3 cells/Lymphocytes in Blood

334

2535

1.24

3.63

1.8

2.1

74.46

73.46

0.65

328

2436

(3009015) Lactate [Moles/volume] in Synovial fluid

279

1.75

3.63

1.3

1.2

5.78

6.43

mmol/l

0.31

134

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

393

1.63

3.62

1.0

0.02

0.30

u/ml

1.94

237

(3036180) Methadone [Presence] in Urine

2.59

3.55

1.8

2.5

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.41

3.55

1.0

1.1

182.00

222.38

pmol/l

0.30

(37019676) Renin [Units/volume] in Plasma --supine

2.84

3.54

1.0

1.1

103.37

63.53

mu/l

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

381

1.63

3.53

2.8

61.24

64.09

pmol/l

0.13

328

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

183

1291

1.34

3.53

1.8

2.1

176.22

159.57

1.20

176

1220

(3011436) Histone Ab [Units/volume] in Serum

104

666

1.47

3.52

1.1

—

27.91

u/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

655

5310

1.16

3.51

1.1

0.18

0.34

u/ml

1.74

244

1577

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

399

3099

1.21

3.50

4.3

5.3

152.60

96.75

u/ml

0.61

125

1091

(3036782) Glucose [Moles/volume] in Pleural fluid

326

2481

1.24

3.48

1.4

1.3

6.73

6.22

mmol/l

2.50

299

2309

(3045788) Cell count panel - Pleural fluid

318

2414

1.24

3.47

1.5

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

188

1.90

3.44

1.1

1.2

36.88

19.49

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

235

1727

1.28

3.39

1.1

—

(3048879) Bone marrow aspiration report

104

674

1.45

3.34

1.3

2.0

2.00

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

2.74

3.33

1.3

1.0

0.94

1.46

u/field

0.95

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

4.98

3.32

1.0

1.1

1.10

0.82

u/ml

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

222

1627

1.29

3.28

1.2

1.3

980.00

1061.92

titre

0.42

344

(3000919) Neutrophils/Leukocytes in Pleural fluid

585

1.48

3.26

1.3

1.4

26.49

22.00

0.74

538

(3041918) Cholesterol [Moles/volume] in Pleural fluid

464

1.54

3.25

1.3

1.2

1.54

1.74

mmol/l

0.65

285

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

928

7754

1.13

3.24

1.3

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

300

2283

1.24

3.24

1.2

1.3

0.68

0.66

ratio

0.17

186

1295

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

271

2040

1.25

3.22

1.1

1.22

1.10

u/l

0.37

108

819

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

245

1823

1.27

3.22

1.5

1.6

2667433.18

1757021.26

iu/ml

0.34

117

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

746

6154

1.14

3.18

1.1

20.21

14.75

au/ml

1.04

176

1727

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

371

1.60

3.16

1.1

1.0

0.60

5.80

u/ml

0.56

181

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

712

5861

1.15

3.14

2.8

3.6

581.59

873.49

u/ml

0.58

638

5310

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

116

2.11

3.14

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

621

1.46

3.13

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

148

1.97

3.13

1.1

1.0

0.10

0.08

0.87

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

251

1880

1.26

3.13

1.2

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

278

1.69

3.13

1.2

0.33

0.61

iu/ml

2.15

137

(3033099) Centromere Ab [Titer] in Serum

125

850

1.38

3.10

1.1

—

(3011412) CD3 cells [#/volume] in Blood

399

3142

1.20

3.08

2.1

2.5

1384.37

1186.55

e6/l

4.57

353

2744

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.42

3.07

1.0

0.33

0.05

u/ml

0.59

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

422

3343

1.19

3.05

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

181

1306

1.31

3.04

2.6

2.5

52.62

50.77

umol/l

0.30

154

1149

(3027874) Urate [Moles/volume] in Urine

2.23

3.03

1.1

1.71

1.77

mmol/l

0.05

(3038071) Oxygen [Partial pressure] in Mixed venous blood

100

657

1.43

3.02

7.7

8.8

6.12

5.59

kpa

0.88

100

657

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

535

1.48

2.98

1.1

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

247

1.72

2.96

1.4

7.68

14.19

pmol/l

1.59

200

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

483

1.50

2.95

1.2

1.4

80.17

279.31

ng/l

0.56

297

(3042010) Triglyceride [Moles/volume] in Pleural fluid

379

1.56

2.92

1.3

1.2

1.42

1.17

mmol/l

0.11

245

(40757373) Influenza virus identified in Isolate

492

1.49

2.91

1.7

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

181

1316

1.30

2.90

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2220

19474

1.08

2.88

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1200

10261

1.10

2.81

3.0

3.7

1067.16

1949.67

u/ml

0.52

1008

8887

(3011897) Casein IgE Ab [Units/volume] in Serum

102

683

1.41

2.81

1.1

1.2

0.17

2.20

u/ml

1.43

102

675

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

141

995

1.33

2.81

1.8

1.7

191.78

118.39

au/ml

0.96

131

(3052592) Norovirus Ag [Presence] in Stool

475

1.49

2.77

1.3

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

377

1.55

2.76

1.3

57.75

52.89

0.32

184

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3241

28843

1.06

2.76

3.5

4.4

24.93

25.68

ug/l

0.05

2562

22896

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

245

1862

1.24

2.74

2.3

1.7

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

245

1862

1.24

2.74

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

346

2724

1.20

2.73

1.5

1.4

26.71

34.96

nmol/l

3.62

304

2529

(3009871) Measles virus Ab [Titer] in Serum

187

1379

1.28

2.71

1.6

4297.12

3444.32

titre

0.45

227

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

172

1256

1.29

2.69

1.0

0.76

0.55

u/ml

0.30

166

1232

(3010370) Gastrin [Moles/volume] in Serum or Plasma

502

1.46

2.67

1.8

42.83

43.59

pmol/l

0.03

429

(3003157) Bacteria [#/volume] in Mother's milk

2.24

2.66

4.2

7.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

187

1384

1.27

2.64

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

187

1384

1.27

2.64

1.5

1.6

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.13

2.62

1.1

0.81

1.42

u/field

1.01

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

184

1361

1.27

2.62

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

318

2500

1.20

2.57

1.6

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

114

791

1.36

2.57

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

153

1.85

2.56

1.0

1.2

1.04

1.25

u/field

0.71

102

(3034426) Prothrombin time (PT)

151

1093

1.30

2.55

1.3

1.2

27.52

28.08

0.58

151

1093

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

729

1.37

2.53

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

157

1146

1.29

2.50

2.0

2.2

63.06

58.61

ug/l

0.44

157

1118

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

441

1.47

2.47

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

306

1.57

2.44

1.6

1.5

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

2.25

2.44

15.0

8.3

50.36

45.54

0.24

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

154

1125

1.29

2.44

1.1

3.17

6.00

u/ml

—

(3000219) Insulin receptor Ab [Presence] in Serum

6.72

2.44

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

103

2.01

2.40

1.1

1.5

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

648

1.38

2.40

1.3

1.4

1.49

2.85

1.88

553

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.13

2.40

1.1

—

mmol/l

—

(3016031) Almond IgE Ab [Units/volume] in Serum

286

1.58

2.38

1.0

1.36

0.64

u/ml

0.24

159

(3036312) Salmon IgE Ab [Units/volume] in Serum

228

1.65

2.36

1.1

0.35

1.74

u/ml

1.21

157

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

258

1.61

2.33

1.2

1.3

15.18

15.86

nmol/l

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

287

2259

1.20

2.33

2.1

2.6

562.15

512.26

e6/l

1.07

235

1811

(3005532) Lymphocytes/Leukocytes in Pleural fluid

109

767

1.34

2.28

1.3

1.4

60.56

61.75

0.13

639

(3010503) CD19 cells [#/volume] in Blood

243

1888

1.21

2.27

2.4

2.6

193.62

253.48

e6/l

0.51

234

1841

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

776

1.33

2.27

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

1032

1.29

2.24

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

406

1.46

2.20

1.0

0.15

1.57

u/ml

0.72

183

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

134

1.83

2.18

1.5

0.00

0.03

u/l

0.49

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

308

1.53

2.17

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

144

1062

1.28

2.17

2.5

3.1

29.52

28.47

umol/l

0.47

825

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

440

1.43

2.14

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

122

1.85

2.11

1.1

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

295

2354

1.18

2.09

1.6

1.8

4.38

3.48

mg/l

2.59

281

2268

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.96

2.07

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

116

1.87

2.07

1.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.27

2.07

1.0

1.1

0.04

0.61

u/ml

1.26

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

109

780

1.32

2.07

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.08

2.05

1.1

0.02

0.10

g/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

194

1.65

2.04

1.2

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

314

1.50

2.01

1.0

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

399

1.44

2.01

1.0

0.08

0.39

u/ml

1.02

187

(3042111) Morphology [Interpretation] in Bone marrow Narrative

533

4455

1.13

2.00

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

153

1.72

1.97

2.4

2.3

0.76

0.62

ug/l

1.25

153

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

182

1.65

1.95

1.3

1.8

195.64

180.22

ug/g

0.21

154

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

110

797

1.30

1.93

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

679

7066

0.90

1.92

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

104

1269

0.77

1.92

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

242

1.56

1.92

1.0

0.21

0.15

u/ml

0.18

242

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

517

4330

1.13

1.90

1.7

1.8

4320.00

3247.45

titre

0.20

145

(3017509) Phencyclidine [Presence] in Urine

428

1.41

1.89

1.8

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

124

1472

0.79

1.85

1.1

—

(4212803) Bone marrow aspirate examination

200

1.60

1.84

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

208

1631

1.20

1.84

1.3

54.86

66.69

0.85

193

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

290

2341

1.17

1.83

2.3

2.7

240.58

226.49

e6/l

0.52

249

1976

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

509

4274

1.12

1.81

1.2

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

115

1.80

1.81

1.0

0.01

0.06

u/ml

1.61

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

301

1.47

1.76

1.6

0.66

1.86

mg/l

3.41

199

(3020356) Listeria sp identified in Specimen by Organism specific culture

286

1.48

1.75

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

372

1.42

1.74

1.2

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

249

1.51

1.72

1.3

22.68

26.66

0.33

192

(3009883) Potato IgE Ab [Units/volume] in Serum

2.30

1.69

1.0

0.01

0.36

u/ml

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

105

774

1.28

1.67

1.2

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

692

1.29

1.65

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

399

3323

1.13

1.65

1.9

2.0

24.97

25.96

ug/l

0.10

387

3261

(3002621) Streptococcal DNAse B [Units/volume] in Serum

290

1.46

1.65

1.0

1.1

187.91

325.17

u/ml

1.58

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

369

1.40

1.63

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

409

1.38

1.63

1.2

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

378

1.39

1.61

1.9

1.7

1.84

1.61

mg/l

0.49

315

(3005011) Chlamydia sp Ab [Titer] in Serum

442

1.36

1.61

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1267

12726

0.93

1.61

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

103

762

1.27

1.60

2.7

2.8

76.49

102.88

ng/l

1.62

408

(3019174) dRVVT (LA screen)

300

1.44

1.60

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

363

1.40

1.59

1.0

3.69

1.74

u/ml

0.22

275

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.86

1.57

1.0

6.32

2.74

u/ml

0.37

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

157

1.62

1.56

3.5

3.6

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

294

1.44

1.56

1.6

0.75

1.27

mg/l

0.87

185

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

294

1.44

1.56

1.6

2.76

4.15

mg/l

0.91

188

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

294

1.44

1.56

1.6

0.74

2.74

mg/l

5.37

209

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

294

1.44

1.56

1.6

0.33

0.89

mg/l

2.21

201

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

294

1.44

1.56

1.6

2.23

2.07

mg/l

0.07

220

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

294

1.44

1.56

1.6

0.98

2.23

mg/l

2.35

196

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

294

1.44

1.56

1.6

1.67

2.45

mg/l

0.77

205

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

373

1.39

1.55

1.0

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

203

2246

0.85

1.54

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

454

1.35

1.54

1.1

1.3

31.87

42.93

mg/l

1.85

387

(3025130) Human papilloma virus identified in Specimen

665

6836

0.91

1.54

1.7

1.9

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

295

1.44

1.53

1.6

2.04

1.72

mg/l

0.28

216

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

295

1.44

1.53

1.6

0.76

2.14

mg/l

3.33

177

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

264

1.46

1.53

1.4

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.88

1.53

1.0

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

242

1.48

1.50

1.0

0.07

2.40

u/ml

2.14

190

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

152

1.61

1.49

1.1

—

(40758358) Immune stain study

123

1.68

1.48

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

646

1.28

1.48

1.4

1.2

277.76

274.61

ug/l

0.00

349

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

329

1.40

1.48

1.4

1.3

66.59

264.16

u/l

0.79

242

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

3.14

1.43

1.0

1.1

173.20

164.20

g/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1292

12909

0.94

1.43

1.5

1.16

1.17

ratio

0.15

755

7707

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

103

776

1.25

1.41

1.1

1.2

96.20

87.47

0.68

207

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

103

777

1.25

1.40

1.1

1.2

67.06

76.97

0.60

198

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

2.44

1.40

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

309

1.40

1.7

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1297

12945

0.94

1.39

1.5

1.17

1.18

ratio

0.11

767

7812

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1297

12944

0.94

1.39

1.5

0.94

0.95

ratio

0.26

760

7743

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

208

1.49

1.39

1.2

1.1

8.79

9.47

u/l

0.10

208

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

302

1.40

1.38

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

310

1.40

1.38

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

334

1.38

1.37

1.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

383

1.35

1.36

1.0

0.02

1.10

u/ml

1.28

187

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

781

6811

1.08

1.35

1.3

3.44

3.48

ug/l

0.06

710

6176

(21494434) Karyotype in Bone marrow

286

2369

1.14

1.35

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

122

942

1.22

1.35

1.8

2.0

2.18

1.78

ratio

1.72

117

911

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.17

1.35

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.79

1.34

1.1

0.05

0.13

g/l

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

417

0.68

1.34

7.5

8.7

0.39

0.35

umol/l

0.17

373

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

681

1.26

1.34

1.1

0.36

3.97

u/ml

2.67

446

(3037692) Legionella sp identified in Specimen by Organism specific culture

131

1021

1.21

1.33

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

485

1.30

1.29

6.2

6.9

10.04

10.68

1.43

485

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

275

1.40

1.28

1.3

1.2

0.04

0.39

u/ml

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

127

0.44

1.27

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

117

907

1.21

1.27

1.4

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

120

933

1.21

1.26

2.8

3.2

2.00

1.83

ratio

0.63

110

860

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

260

1.41

1.26

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

236

1943

1.14

1.25

6.1

7.3

105.02

52.30

ug/l

0.31

131

1303

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

342

1.35

1.22

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

255

1.40

1.20

1.1

22.14

23.00

u/l

0.11

162

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.95

1.19

1.0

1.1

102.40

92.59

u/ml

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

344

1.34

1.18

2.8

3.5

37.13

42.55

umol/l

1.10

297

(3015956) Eosinophils/Leukocytes in Blood by Manual count

434

1.30

1.18

1.8

2.5

2.77

2.55

0.14

429

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

211

1732

1.15

1.18

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

301

2529

1.12

1.17

1.0

1.1

0.74

3.02

u/ml

2.15

113

788

(3047185) IgG [Mass/volume] in Urine

1.83

1.17

1.1

1.0

—

45.20

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.09

1.17

1.9

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.09

1.17

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.09

1.17

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.09

1.17

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.09

1.17

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.09

1.17

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

103

1.64

1.16

1.1

1.3

0.69

1.20

u/field

1.68

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

103

1.64

1.16

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

102

789

1.22

1.15

1.1

24.15

30.40

iu/ml

0.77

102

789

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.03

1.13

1.0

1.2

1.87

1.27

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

126

1.57

1.13

5.3

9.8

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

2.35

1.12

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

189

1.44

1.08

3.8

5.8

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

151

1.50

1.06

1.0

1.1

0.01

1.33

u/ml

1.85

151

(3017461) Flecainide [Moles/volume] in Serum or Plasma

151

1.50

1.06

1.8

1.6

0.67

0.72

umol/l

0.18

117

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

131

1047

1.18

1.06

1.4

1.2

26.43

20.03

0.35

176

(3045683) HLA typing for celiac disease panel - Blood or Tissue

260

2182

1.12

1.06

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

566

0.76

1.04

2.8

3.3

39.59

44.37

0.75

566

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

279

1.35

1.03

1.1

1.2

88.80

93.94

titre

0.19

279

(3050794) Legionella sp Ab [Presence] in Serum

263

1.36

1.03

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

361

1.30

1.03

1.0

2.64

1.44

u/ml

0.20

274

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

565

0.77

1.03

5.7

6.5

9.43

8.73

0.27

565

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

185

1524

1.14

1.02

1.7

1.9

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

184

1.43

1.02

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.24

1.01

1.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

140

1133

1.16

0.99

1.8

8083.29

26295.74

u/ml

0.82

152

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.67

0.97

1.0

184.57

372.53

u/l

0.86

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.80

0.96

1.0

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

195

1.40

0.95

1.1

36.38

58.51

u/l

1.62

162

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

211

1.38

0.94

1.6

1.4

27.36

36.86

0.64

140

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.78

0.94

2.4

2.1

29.82

28.24

0.14

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.78

0.94

2.5

4.6

—

(3022229) Phosphate [Moles/volume] in Urine

188

1.40

0.92

1.6

2.0

14.45

19.23

mmol/l

1.26

162

(3006245) CD3-CD19+ cells/cells in Blood

169

1397

1.14

0.92

1.8

2.3

9.80

9.51

0.12

163

1301

(3004959) Base excess in Arterial cord blood by calculation

1.57

0.89

1.1

0.98

-1.58

mmol/l

—

(21494815) CD4 cells/Lymphocytes in Specimen

332

2857

1.09

0.89

2.0

2.2

43.70

39.35

6.06

324

2809

(3046861) Legionella sp Ag [Presence] in Urine

183

1.39

0.86

1.2

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

131

1072

1.15

0.84

1.6

2.2

0.28

0.56

e9/l

0.51

503

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

141

1160

1.14

0.84

1.0

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

28005

264689

0.98

0.83

27.9

18.0

330.05

332.76

g/l

307.65

27865

263316

(3012989) Citrate [Moles/time] in 24 hour Urine

1.66

0.83

2.4

1.2

2.23

2.18

mmol/24h

0.04

(40758292) HTLV I+II Ab panel - Serum

639

0.81

0.82

1.2

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

209

1.35

0.82

1.2

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

417

1.24

0.82

1.4

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

637

0.81

1.8

2.3

—

(3006598) pH of Arterial cord blood

1.52

0.80

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

179

1884

0.89

0.79

2.4

2.8

44.24

39.52

3.14

117

1021

(3009992) Blasts/cells in Bone marrow

0.00

0.79

0.0

1.8

—

15.67

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1394

13626

0.96

0.77

1.5

49.40

63.66

ug/l

33.01

1143

11358

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

362

1.25

0.76

1.2

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.61

0.76

1.1

1.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

164

1.38

0.75

1.2

1.3

1.34

1.74

mg/l

1.03

139

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

117

1.45

0.73

1.1

268.00

278.81

nmol/l

0.07

117

(40768795) Lymph node Pathology biopsy report

302

3080

0.92

0.72

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

203

1730

1.10

0.71

1.3

1.2

13.04

9.33

mm/h

3.99

203

1730

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

162

1364

1.12

0.71

1.1

346.24

446.96

ng/l

0.21

376

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.51

0.70

1.5

1.1

31.39

46.66

umol/24h

0.42

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

316

1.25

0.69

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.69

0.69

2.0

2.5

—

(3024869) Neuronal Ab [Presence] in Serum

513

1.19

0.69

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

352

0.77

0.66

1.9

2.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

683

1.16

0.64

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

683

1.16

0.64

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

570

1.17

0.64

4.6

6.5

—

3133.09

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

1.59

0.62

1.0

1.1

—

371.20

—

(3010937) Rubella virus Ab [Presence] in Serum

271

1.25

0.61

1.1

—

(3014891) Appearance of Pleural fluid

271

1.25

0.61

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

248

2154

1.08

0.61

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

187

0.70

0.60

2.7

5.7

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

19.42

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.60

0.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

130

0.65

0.60

4.6

3.8

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.57

0.60

1.0

1.1

—

(40760512) CD34 cells/cells in Bone marrow

0.00

0.60

0.0

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

147

1.34

0.60

1.1

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

205

1.29

0.59

1.0

1.1

15.83

16.57

iu/ml

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

247

1.26

0.59

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

197

0.72

0.59

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

324

1.22

0.58

2.2

0.83

0.60

u/field

0.72

324

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

1.51

0.58

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

268

2713

0.93

0.58

1.1

19.11

18.30

u/ml

0.14

1135

(3014599) Egg white IgE Ab [Units/volume] in Serum

280

2454

1.07

0.56

1.1

0.66

4.23

u/ml

1.99

592

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

683

1.14

0.56

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

105

878

1.13

0.56

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

105

878

1.13

0.56

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

105

878

1.13

0.56

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

105

878

1.13

0.56

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

381

3377

1.06

0.55

1.5

—

(3049233) Organic acids panel - Urine

1.61

0.55

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

150

1.32

0.54

12.5

15.3

110.86

104.77

g/l

1.23

150

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

134

1.33

0.53

1.1

1.0

8.36

8.81

0.35

120

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

529

1.16

0.52

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

266

0.78

0.52

2.7

3.5

2.08

2.20

mg/l

0.10

233

(46235168) Fasting glucose [Moles/volume] in Blood

355

1.19

0.52

1.6

1.9

7.17

7.07

mmol/l

0.06

102

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.59

0.51

1.2

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

244

1.23

0.51

2.1

3.0

21.18

59.83

pmol/l

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

135

1.32

0.51

1.2

1.0

36.72

36.00

0.35

123

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

135

1.32

0.51

1.2

1.0

19.90

21.46

0.77

121

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

180

0.73

0.50

6.2

4.9

—

(4133840) Spirometry

102

861

1.11

0.49

1.1

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

103

0.64

0.48

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.47

0.46

2.1

1.3

1.92

2.05

g/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

133

0.71

0.45

1.2

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

292

1.19

0.44

1.1

2.17

1.66

umol/24h

1.64

292

(3003740) Influenza virus B Ag [Presence] in Specimen

785

7138

1.04

0.43

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

785

7142

1.03

0.42

1.1

—

(3022475) Manganese [Moles/volume] in Blood

205

0.78

0.42

1.1

1.3

0.14

0.16

umol/l

0.64

205

(3034614) HLA Ag [Interpretation]

1.38

0.41

1.0

1.3

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

0.41

0.0

3.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

573

5187

1.04

0.41

1.1

3.16

2.86

eliau/ml

0.18

231

2610

(3022670) pH of Venous cord blood

1.43

0.41

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

1.47

0.40

1.0

1.1

33.40

64.13

u/ml

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

191

1921

0.94

0.40

1.0

246.42

331.43

ng/l

3.53

146

1421

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.40

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.40

0.0

1.2

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

218

1.21

0.40

1.0

11.43

16.44

u/ml

0.50

177

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

340

1.16

0.39

1.4

13.10

13.92

0.06

182

(3009677) Dengue virus Ab [Presence] in Serum

161

0.76

0.39

1.1

1.2

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

464

1.14

0.39

1.8

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

411

1.14

0.39

1.1

1.2

—

(3041184) Isoniazid [Presence] in Urine

1.38

0.38

2.0

2.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.34

0.38

1.3

1.1

3.33

2.63

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

220

1.20

0.37

1.4

2.8

23.84

10.92

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

193

1931

0.94

0.36

1.0

31.85

41.06

ng/l

4.04

144

1407

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.36

0.36

1.3

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

238

1.19

0.36

2.4

2.5

234.80

417.42

umol/l

1.30

231

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.38

0.36

1.3

1.8

102.40

138.46

ug/l

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.38

0.36

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.63

0.35

1.2

2.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

178

1.22

0.35

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

193

1928

0.94

0.35

1.0

864.42

754.73

ng/l

2.64

142

1380

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.33

0.34

1.3

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

209

0.81

0.34

1.2

0.14

6.10

u/ml

2.37

174

(3020650) Glucose [Presence] in Urine

139

1219

1.07

0.34

1.8

1.6

0.06

0.05

estimate

0.20

139

1219

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

219

0.82

0.34

1.4

2.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.31

0.33

1.0

1.1

4683.33

3631.63

titre

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

400

1.13

0.32

2.6

2.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

190

1690

1.06

0.31

1.7

1.89

2.59

u/ml

0.44

446

(3036071) Salmonella sp Ab [Titer] in Serum

125

1098

1.07

0.30

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

770

0.92

0.30

1.1

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

191

1.18

0.29

1.1

1.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

139

1.22

0.29

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

472

0.90

0.27

1.3

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.25

0.27

1.8

1.4

67.13

72.08

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

388

1.12

0.27

1.1

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

194

1.16

0.25

1.0

0.08

7.56

u/ml

0.54

102

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

652

1.08

0.25

1.1

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

571

1.09

0.25

3.7

2.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

347

1.11

0.24

1.2

1.4

—

(4035726) Immunohistochemistry procedure

2796

26042

1.01

0.22

1.4

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

3.54

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

180

1.15

0.21

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

243

2206

1.04

0.21

2.3

2.6

0.86

0.67

e9/l

5.95

230

2124

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

414

1.09

0.21

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

225

1.13

0.20

1.3

1.5

—

(4038314) Semen analysis, post vasectomy

166

0.85

0.20

1.3

1.2

—

(40765096) Chromosome analysis panel by Banding

848

0.94

0.19

1.1

1.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

155

1.15

0.19

1.1

1.3

—

14114.50

—

(3045142) Bone marrow Pathology biopsy report

347

3180

1.03

0.18

1.3

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

192

1.13

0.17

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

121

1.17

0.17

1.1

1.2

0.06

0.08

g/l

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.22

0.17

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

547

1.07

0.17

1.0

5.50

8.11

u/ml

0.86

547

(3018001) Oat IgE Ab [Units/volume] in Serum

291

0.91

0.17

1.0

0.09

0.73

u/ml

1.12

167

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

347

1.08

0.16

1.3

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.11

0.16

2.3

5.7

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

149

1.14

0.15

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.21

0.15

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.81

0.14

1.6

1.1

219.14

276.75

u/ml

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

204

1.11

0.14

1.2

1.1

—

(3013762) Body weight Measured

0.83

0.13

1.0

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

509

0.94

0.13

3.4

2.7

3910.48

1431.63

u/l

0.63

456

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

225

2171

0.97

0.13

1.4

1.3

124.05

186.21

pmol/l

3.72

225

2171

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

499

0.94

0.13

1.6

1.7

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

168

0.90

0.11

4.0

3.9

0.00

estimate

—

(3022725) Serotonin [Moles/volume] in Serum

126

1.12

0.11

1.3

1.4

657.13

889.06

nmol/l

0.56

119

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

235

0.92

0.10

1.0

1.1

12.42

24.27

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

235

0.92

0.10

1.0

1.1

43.20

28.63

u/ml

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

629

0.96

0.10

1.5

1.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

205

0.92

0.10

1.9

2.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

311

0.94

0.10

2.8

2.9

1.62

1.18

mg/l

0.50

212

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

191

1.08

0.09

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

173

1.09

0.09

1.2

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.03

0.07

1.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

138

1.09

0.07

1.1

1.0

0.07

0.42

u/ml

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

479

0.96

0.07

2.2

2.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

134

0.91

0.06

1.1

1.0

0.19

0.58

u/ml

—

(3007542) Rye IgE Ab [Units/volume] in Serum

231

1.06

0.06

1.0

0.60

8.74

u/ml

0.49

107

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

185

1.07

0.06

1.0

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

124

0.91

0.06

1.4

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

114

0.91

0.06

1.7

3.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

144

1378

0.98

0.06

3.2

3.1

—

(3007463) Buprenorphine [Presence] in Urine

168

1.06

0.05

7.6

7.7

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

266

0.96

0.05

1.0

1.1

8.48

6.84

u/ml

0.16

161

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

317

3010

0.99

0.05

3.8

4.3

47.99

52.71

u/ml

0.20

308

2989

(3013862) HLA-DP [Type]

132

0.93

0.04

1.0

—

(3024316) Viscosity of Plasma

151

0.93

0.04

1.1

1.7

1.37

1.58

mpas

—

(3041672) Baker's yeast Ab [Presence] in Serum

198

0.95

0.04

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

350

0.97

0.04

2.6

2.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

207

1.05

0.03

1.3

—

(46236302) HLA-C [Type] by High resolution typing

130

0.94

0.02

1.0

—

(40760409) HLA-A [Type] by High resolution

129

0.95

0.01

1.0

—

(40760410) HLA-B [Type] by High resolution

129

0.95

0.01

1.0

—

(40763590) HLA-DQ beta [Type]

129

0.95

0.01

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

135

1.05

0.01

1.4

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

243

2278

1.00

0.01

1.0

0.36

0.94

u/ml

1.04

508

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

222

0.97

0.00

1.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

120

1.02

0.00

1.1

1.0

0.18

1.03

u/ml

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

166

1564

1.00

0.00

6.3

6.5

4231.32

2910.02

u/ml

0.11

282

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8342

78493

1.00

0.00

5.0

5.3

2.15

2.78

ug/l

2.11

7475

71839

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

608

1.01

0.00

1.7

1.9

1.84

3.44

ug/l

1.06

375

(3033086) Enterovirus Ab [Titer] in Serum

104

1.00

0.00

1.0

1.1

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.1

—

1.37

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

11.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.90

-0.00

1.0

1.1

—

(3045191) Normetanephrine [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

2.27

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

8.54

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

571.80

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.96

-0.00

1.0

1.1

—

(3012864) Amino acids [Identifier] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITY and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITY	2.165 [1.95, 2.41]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.088

During the follow-up period (1.1.1998 — 31.12.2019), 8290 out of 89525 females with E4_OBESITY died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITY	2.128 [1.93, 2.35]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 9824 out of 62365 males with E4_OBESITY died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITY.

N-year risk	Females	Males
1	0.18%	0.361%
5	1.077%	2.149%
10	2.722%	5.613%
15	5.357%	10.93%
20	9.317%	18.155%

Relationships between endpoints

↥

Index endpoint: E4_OBESITY – Obesity

GWS hits: 93

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Obesity

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints